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Bacillus subtilis is an industrially important organism because of its ability to 
produce enzymes and antibiotics on a commercial scale. It is considered the Gram 
positive counterpart of E. coli in terms of its genetic and molecular biological 
accessibility. Also, it is a model organism for the study of sporulation, an example of 
prokaryotic cellular differentiation.  Sporulation involves several groups of genes that 
encode apparent metabolic pathways, many of which remain uncharacterized at the 
biochemical level.  The mmg (mother cell metabolic gene) operon in B. subtilis strain 168 
is one of these groups, and is transcribed only during an early stage of sporulation.  This 
operon contains mmgABC, which are similar to genes from fatty acid metabolism, and 
mmgDE and yqiQ, which encode homologs of enzymes involved in the 2-methylcitric 
acid cycle. 
 The focus of this work will be on the biochemical characterization of the mmgB 
protein, which is similar by sequence to 3-hydroxyacyl-coenzyme A (CoA) 
dehydrogenase from a wide variety of organisms. So far, we successfully cloned and 
overexpressed mmgB, and purified the protein at a yield of 4.0 mg/liter of culture.  A 
spectrophotometric assay and mass spectrometry showed that this enzyme indeed 
possesses 3-hydroxybutyryl-CoA dehydrogenase activity (E.C. 1.1.1.157) for the 
production of acetoacetyl-CoA.  This oxidation specifically requires NADP
+
, and has an
 
optimal pH of 9.8. We will describe these results including the steady-state kinetics that 
the enzyme follows.   
As previously said, the downstream 3 ORF’s of the mmg operon – mmgD, mmgE 
and yqiQ are proposed to encode for the methylcitric acid cycle. Also, as a part of a 
master’s thesis, it has been shown by the Reddick lab that mmgD encodes for a 
citrate/methylcitrate synthase with a substrate preference for propionyl-CoA over acetyl-
CoA. This fact encouraged us even more with reference to the involvement of the mmg 
operon in the methylcitric acid cycle, a pathway for propionate metabolism. So, our goal 
was to create conditional knockout mutants of the mmg operon and study the growth 
characteristics of the organism by feeding studies using propionate as sole carbon source. 
Eventually, we would also want to perform some NMR analysis of the cultures of the 
mutants for the intermediates of methylcitric acid cycle/propionate metabolism.  
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CHAPTER I 
BACILLUS SUBTILIS 
I.A. Description 
Bacillus subtilis (B.subtilis) is a ubiquitous, aerobic, endospore-forming, rod-
shaped bacterium commonly found in soil, water resources and in association with 
plants
1
. It is the best characterized member among Gram-positive bacteria and is 
considered the Gram positive counterpart of Escherichia coli (E.coli). B.subtilis was one 
of the first organisms to be fully sequenced
1
. The Bacillus subtilis genome of 4,214,810 
base pairs comprises 4,100 protein-coding genes. Among these genes identified only 
about 1000 have been experimentally characterized
2
.  
I.B. Significance 
 B. subtilis and its near relatives are an important source of enzymes such as 
amylases and proteases. The bacterium is commercially important because of its ability to 
produce the enzymes at gram/liter concentrations
1
. It has therefore been extensively 
studied for protein secretion and is under development as a host for the production of 
heterologous proteins
1
. B.subtilis is also employed in the production of a variety of 
secondary metabolites and chemical agents such as antibiotics and surfactants
1
. Apart 
from these, it also exhibits some interesting features like sporulation, an example of 
prokaryotic cell differentiation, and the development of natural competence
3, 4
. Because 
of the underlying mechanisms governing competence and sporulation, B.subtilis has 
2 
 
emerged as a popular prokaryotic model organism. Naturally competent B.subtilis cells 
have the ability to take up exogenous DNA and to integrate it into their genome via 
homologous recombination. This feature has made B.subtilis amenable to detailed genetic 
and molecular biology analyses
4
. 
For the above mentioned reasons, the genetics, biochemistry, physiology and 
molecular biology of B.subtilis have been studied extensively. Today, availability of 
powerful genetic tools facilitates the functional analysis of B.subtilis
1
.  
I.C. Sporulation 
B. subtilis grows and divides by a vegetative cycle under normal environmental 
and physiological conditions
3
. However, upon onset of harsh environmental or 
physiological conditions such as nutritional limitation and cell cycle perturbation, the cell 
can undergo sporulation as a survival strategy
3
. Endospores are metabolically dormant 
and have the ability to survive harsh conditions and most importantly they can germinate 
back to a vegetative cell in favorable conditions
3
.  
Usually B.subtilis cells enter sporulation towards the end of the exponential phase 
or about the beginning of stationary phase of the growth period when nutrients become 
limiting
4, 5
. Under normal conditions, glucose is the preferred carbon source. However 
during scarcity, it makes use of other carbon sources such as fatty acids
5
.  
I.C.1. Overview of Sporulation in B.subtilis 
Sporulation in B.subtilis is a primitive developmental process that results in 
endospores, which are small, dormant cells that exhibit remarkable resistance to heat, 
desiccation, radiation and chemical insult
3
. The precise identity of the signals inducing 
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sporulation is still an open question; however, recent studies suggest strategies by which 
B.subtilis integrates diverse signals responsible for the onset of sporulation
6, 7
.  
Although sporulation is induced because of starvation, it is not initiated 
immediately when growth slows down due to nutritional scarcity. Alternatives such as 
chemotaxis, production of antibiotics to destroy potential contenders, and secretion of 
hydrolytic enzymes to scavenge extracellular proteins and carbohydrates will be 
explored. It might also undergo induction of competence for uptake of exogenous DNA 
for consumption. So, sporulation is the last ditch response to starvation and is suppressed 
until alternative responses are proved inadequate. B. subtilis cells also monitor various 
internal conditions viz., chromosome integrity, and the state of chromosomal replication 
and functioning of the Krebs cycle before initiating sporulation. These controls are 
presumably to ensure that, once started, sporulation can be successfully completed
7
. 
Thus, B.subtilis decides to sporulate by integrating a wide range of environmental 
and physiological signals culminating in the activation of Spo0A, a trigger for 
sporulation
4, 6-8
. It is a response regulator component of the two-component signaling 
systems typical to bacteria and also a transcription factor.  All these signals are channeled 
into a phosphorelay which is actually responsible for the activation of Spo0A via 
phosphorylation (Spo0A~P)
4, 6, 7
. 
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Environmental/Physiological conditions
Starvation
 
Figure 1: Two-component regulatory systems/Phosphorelay
4
 (adapted). 
 
 
I.C.1.a Two-component regulatory systems 
Initiation of sporulation is controlled by proteins belonging to the family of two-
component regulatory systems. These signal transduction systems are used in bacteria to 
control gene expression in response to physiological signals, instead of kinase cascade 
pathways that play pivotal roles in signal transduction in eukaryotes. Two-component 
regulatory systems consist of an upstream sensor component which usually is a histidine 
protein kinase and, the downstream response regulator component, which usually but not 
always will be a transcription factor
4, 6, 7
.  
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Histidine protein kinases undergo an initial autophosphorylation step in response 
to signals by phosphorylating a conserved histidine residue with ATP as phosphate 
donor. The response regulator then interacts with its cognate histidine protein kinase 
resulting in the transfer of this phosphate form the histidine kinase to the response 
regulator. This phosphate then enters the phosphorelay
4, 6, 7
. 
I.C.1.b. Phosphorelay  
The phosphate entering the phosphorelay causes activation of Spo0A - Spo0A~P 
(Figure 1), a key event in controlling sporulation. There are five histidine protein kinases, 
namely KinA, B, C, D and E, which contribute to the production of Spo0A~P. However, 
unlike most response regulators, Spo0A does not obtain phosphate directly from cognate 
histidine protein kinases. Rather, the phosphate is first transferred from kinase(s) to 
Spo0F, a single domain response regulator, then to Spo0B and finally to Spo0A leading 
to Spo0A~P. This series of inter-protein phosphotransfer reactions is called a 
Phosphorelay
4, 6, 7
.  
I.C.2. Genetics/Biochemistry/Molecular Biology/Physiology 
Sporulation is a perturbation of the normal cell cycle. This process in B. subtilis 
proceeds through a well-defined series of morphological stages.  It is controlled by an 
intricate genetic arrangement.  The activity of the associated genes is controlled by 
various DNA (Deoxyribose Nucleic Acid) binding proteins & RNA (Ribose Nucleic 
Acid) polymerase sigma factors
3, 4
. 
Sporulation begins with the accumulation of Spo0A~P. It initiates the 
transcription of genes and operons which are associated with different stages of 
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sporulation. Throughout the process, different sigma factors of RNA polymerase appear 
which result in the stepwise transcription of different sets of sporulation genes. This in 
turn leads to a series of morphological stages for sporulation
3, 4, 6-8
.  
Series of morphological stages of sporulation (Figure 2): 
 Stage O-vegetative cycle. 
 Stages I & II - polar division and chromosome segregation followed by cell 
specific activation of transcriptional factors in both forespore and mother cell. 
 Stage III – engulfment of forespore by mother cell. 
 Stage IV, V & VI – cortex and coat formation around the endospore. 
 Stage VII – Maturation, lysis of mother cell and release of mature spore. 
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Figure 2: Series of Morphological stages during Sporulation & associated sigma – factors
9
 (adapted). 
 
 
Understanding the regulatory strategies governing sporulation can have broad 
implications on related signal transduction processes. Consequently, a considerable 
amount of research has been done in this area. Despite the availability of massive 
amounts of sequence information in databases and equally powerful computational tools 
it is not possible to assign precise functional significance to a particular coding sequence 
based on just sequence information and computational data. Also it is important to relate 
identified genome structure to intermediary metabolism, since they complement each 
other. Hence, experimental analysis is the definitive approach as it was before in order to 
characterize a particular gene
1, 3, 5-7
. 
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I.D. The σE controlled mmg operon 
Many metabolic enzymes are induced during the various stages of sporulation. 
Nevertheless, very little is known about their effects. In an effort to identify genes that 
are induced during the intermediate stages of sporulation, Bryan et al. discovered the 
mmg operon controlled by the σ
E
 transcription factor. Since σ
E
 is specific to mother cell, 
the operon is named “mmg,” which stands for mother cell metabolic gene
10
. 
The mmg operon consists of six open reading frames (ORF’s) namely mmgA, B, 
C, D, E and yqiQ. Bryan et al. discovered mmgA through part of mmgE. The genome 
sequence in 1997 (Kunst et al) revealed the rest of mmgE, and that this operon also has a 
6
th
 gene, yqiQ (Figure 3)
10
.  
 
 
 
Figure 3: Schematic of mmg operon from B.subtilis
10
 (adapted). 
 
 
Sequence homology data is suggestive that the operon is associated with the 
metabolic activity of the cell. All the ORF’s show high similarity to well - established 
metabolic enzymes. Sequence homology data suggests that mmgA, mmgB and mmgC, are 
involved in fatty acid metabolism (β-oxidation), while the latter half of the operon, which 
includes mmgD, mmgE and yqiQ, encodes a part of the methyl citric acid cycle
10-12
. 
Bryan et al. also discovered that the transcription of the mmg operon is under 
control of σ
E
, mmgO and CcpA. MmgO is a 14 base-pair catabolite responsive element 
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(CRE) located in the promoter region, downstream of the transcription start site of mmg 
operon. CcpA is a protein which binds to mmgO and facilitates the repression of 
transcription by glucose. This means that the operon is transcribed only by σ
E
 (early 
sporulation in the mother cell) and when glucose is absent. These findings reinforce the 
idea of involvement of mmg operon in energy metabolism during sporulation
5, 10
.  
The Reddick group has thus begun characterizing each of the members of mmg 
operon. The Reddick lab has successfully shown that mmgA encodes a degradative 
acetoacetyl-CoA thiolase
13
. Spencer Russell, a former Master’s student from the Reddick 
lab has proposed that mmgB encodes a 3-hydroxybutyryl-CoA dehydrogenase and 
worked towards its characterization. Also, he showed that mmgC encodes for an acyl-
CoA dehydrogenase
14
. Rejwi Acharya has shown that mmgD is a bifunctional enzyme 
showing both citrate synthase and methyl citrate synthase activities with slight preference 
for propionyl-CoA over acetyl-CoA
15
. The gene mmgE is proposed to exhibit 2-methyl 
citrate dehydratase activity based on sequence homology
10, 12
. Currently Grant Hardesty, 
another Master’s student from the Reddick lab is on his way to biochemically 
characterize this protein. YqiQ, the final member of the operon, is proposed to act as a 2-
methyl isocitrate lyase. William Booth, a former Master’s student from Reddick lab has 
worked on this system and could partially establish this activity
16
. The two metabolic 
pathways which involve these types of enzymes are discussed in detail in the next 
section. 
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I.D.1. Fatty acids/β-oxidation 
Fatty acids occur in all living organisms. They are an important source of carbon 
and also energy. Fatty acids are classified (Figure 4) into straight and branched chain. 
Furthermore the branched chain fatty acids are divided into iso, anteiso and ω-acyclic
17
. 
 
 
 
Figure 4: Classification of fatty acids of genus Bacillus
17
 (adapted). 
 
 
Fatty acids are significant because they play an important role in phospholipid 
synthesis and in the functions of the cell membrane. Consequently, fatty acids are 
important products of the breakdown of cell membrane components
17
. 
Regardless of the arrangement of their carbon skeleton, fatty acids are subjected 
to β-oxidation - a means of energy production. β-oxidation is a pathway of enzyme-
catalyzed reactions that operate in repetitive fashion, progressively degrading fatty acids 
by removing two carbon units every cycle. It involves the oxidation of the β carbon. 
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I.D.1.a Schematic of β-oxidation 
At the onset of β-oxidation, fatty acids will be activated by acyl-CoA 
synthetase/thiokinase, reacting with CoA with the aid of ATP to form a fatty acyl-CoA. 
This fatty acyl-CoA is then degraded to acetyl-CoA molecules via the β-oxidation in a 
cycle of four reaction steps (Figure 5).  
Step-1:   The fatty acyl-CoA is oxidized at the Cα/Cβ position to form a trans Δ²-enoyl-
CoA through dehydrogenation by acyl-CoA dehydrogenase which uses FAD (Flavin 
Adenine Dinucleotide) as a cofactor. 
Step-2:   The trans Δ²-enoyl-CoA formed in step-1 is hydrated by enoyl-CoA hydratase, 
forming a 3-hydroxyacyl-CoA. 
Step-3:   3-hydroxyacyl-CoA undergoes oxidation in the presence of a NAD
+
 dependent 
3-L-hydroxyacyl-CoA dehydrogenase thereby forming the corresponding β-ketoacyl-
CoA. 
Step-4:  The β-ketoacyl-CoA formed in the previous step undergoes Cα/Cβ cleavage in 
presence of CoA catalyzed by β-ketoacyl-CoA thiolase. This leads to formation of acetyl-
CoA and a new fatty acyl-CoA, two carbons shorter than the original which began the 
cycle. 
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Figure 5: Schematic for β-oxidation of fatty acids and propionate metabolism in B.subtilis via methylcitric acid cycle. 
 
 
Each round of β-oxidation produces one molecule each of FADH2, NADH and 
acetyl-CoA. Acetyl-CoA formed will be channeled into citric acid cycle where it is 
oxidized further. This leads to formation of additional three NADH’s and one FADH2. 
Each of these NADH’s and FADH2’s will be reoxidized to NAD
+
 and FAD respectively 
through oxidative phosphorylation leading to the formation of ATP. Thus the purpose of 
β-oxidation is to generate metabolic energy since the complete oxidation of each fatty 
acid yields many ATP’s.  
In B.subtilis, 85% of the membrane lipids consist of branched chain fatty acids
17
. 
If the fatty acid is a branched or odd chain fatty acid, the final round of oxidation will 
13 
 
yield propionyl-CoA also alongside acetyl-CoA. This propionyl-CoA is channeled into 
methyl citric acid cycle (Figure 5). 
I.D.2. Propionate Metabolism/ Methylcitric acid Cycle 
Odd chain fatty acids are a rich source of energy for many microorganisms that 
are soil inhabitants. B.subtilis is one such example. Branched chain fatty acids comprise 
85% of the total fatty acid composition of cell membranes in these organisms
17
. β-
oxidation of these fatty acids yields propionyl-CoA. Propionate can be metabolized via a 
wide range of pathways like the methylcitric acid cycle, α-oxidation, β-oxidation, α-
carboxylation, reductive carboxylation and Claisen condensation to name a few (Figure 
6)
15
. 
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Figure 6:  Various pathways for propionate metabolism
11
 (adapted). 
 
 
The prp operon from Salmonella typhimurium which consists of prpBCDE genes 
was shown to catabolize propionate via the methylcitric acid cycle. Horswill et al., has 
shown that prpE encodes propionyl-CoA synthetase. PrpC encodes 2-methylcitrate 
synthase. PrpD would encode either 2-methylcitrate dehydratase or 2-methylcitrate 
hydratase. Its function is still unclear. PrpB encodes 2-methylisocitrate lyase (Figure 7)
11
. 
2-methylcitrate synthase catalyzes the formation of 2-methylcitrate through aldol 
condensation of oxaloacetate with propionyl-CoA. The 2-methylcitrate formed will be 
subjected to dehydration by 2-methylcitrate dehydratase thus forming 2-methyl-cis-
aconitate which upon subsequent hydration in the presence of aconitase forms 2-
15 
 
methylisocitrate. Since there is no aconitase analogue in the prp operon; it is still unclear 
if 2-methylcitrate dehydratase itself is also responsible for hydration of 2-methyl-cis-
aconitate to 2-methylisocitrate or there is any other enzyme that does this job. 2-
methylisocitrate lyase breaks down 2-methylisocitrate into pyruvate and succinate, the 
last step in the methylcitric acid cycle. 
The pyruvate formed goes either into the citric acid cycle or will be directed 
towards gluconeogenesis. Succinate will be fed into the citric acid cycle where it is 
subsequently oxidized to oxaloacetate to initiate another round of either the citric acid 
cycle, the methylcitric acid cycle or both. 
 
 
 
Figure 7: Schematic of propionate metabolism in S.typhimurium
11
 (adapted). 
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More recently a similar operon was discovered in E.coli and named the prp 
operon. This operon too is associated with propionate metabolism via the methylcitric 
acid cycle (Figure 8)
12
. 
 
 
 
Figure 8: Schematic of propionate metabolism in E.coli
12
 (adapted). 
 
 
Sequence comparisons show that a portion of the mmg operon is homologous to 
prp operons from S. typhimurium and E.coli. B.subtilis counterparts of prp members are 
mmgDE and yqiQ: 2-methylcitrate synthase (MCS), 2-methylcitric acid dehydratase 
(MCD) and 2-methylisocitrate lyase (MCL) respectively. CitB, the only aconitase in 
17 
 
B.subtilis, is considered to play a role in the rehydration of 2-methyl-cis-aconitate to 2-
methylisocitrate as does AcnB (aconitase) from E.coli
10-12, 18
. 
 
 
 
Figure 9: Schematic of proposed functions of mmg operon. 
 
 
To reiterate, one region of the mmg (mmgA, B and C) operon is associated with β-
oxidation, which yields acetyl-CoA/ propionyl CoA as end products. These may enter the 
citric acid cycle or methylcitric acid cycle respectively. Any propionyl CoA is oxidized to 
pyruvate via the methylcitric acid cycle encoded by remaining portion of the mmg 
(mmgD, E and yqiQ) operon (Figure 9). Since these processes operate during sporulation, 
a nutritional deprivation induced state, conservation of every single molecule of 
metabolite which can yield ATP is really important for the cell. 
18 
 
CHAPTER II 
HYPOTHESIS 
II.A. MmgB 
Bacillus subtilis is a model organism for studying sporulation. Sporulation is 
controlled by several genes and operons in association with various DNA binding 
proteins and RNA polymerase sigma (σ) factors
3
. The mmg operon is one such operon 
under the control of σ
E
 factor. The mmg operon becomes metabolically active during 
intermediary stages of sporulation. MmgB is one of the members (a gene) of the mmg 
operon
10
. Based on sequence homology, it is proposed to encode for 3-hydroxy-butyryl-
CoA dehydrogenase (E.C. 1.1.1.157). Thus, our hypothesis is that the mmgB protein is an 
oxido-reductase (Figure 10) catalyzing the oxidation of 3-hydroxy-butyryl-CoA (3-HB-
CoA) to acetoacetyl-CoA (AcAc-CoA). It would use either NAD
+
 or NADP
+
 as the 
cofactor
10, 14, 19
. 
 
 
 
 
Figure 10: Proposed enzymatic reaction catalyzed by mmgB protein. 
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II.B. Goals 
Biochemical Characterization of mmgB: This was initiated by Spencer Russell 
(2007), but he couldn’t establish its enzymatic action. Recently we discovered that the 
nucleotide sequence of mmgB was updated in the genome servers. The new version (864 
bp’s) of the sequence is 132 base pairs longer than the older version (732 bp’s) with 
which Spencer Russell worked (Figure 11)
14
. 
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Figure 11:  Alignments of old and new mmgB gene sequences. 
 
 
So, the first goal was to clone the new, corrected mmgB gene into a suitable 
expression system (pET-200 plasmid). The second goal was to isolate and purify the 
mmgB protein. The final goal was to determine the enzymatic activity of this protein.  
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CHAPTER III 
EXPERIMENTAL SECTION 
III.A. Cloning of the mmgB gene 
 III.A.1. PCR amplification of mmgB gene 
Both forward and reverse primers for the mmgB gene were designed in order to 
amplify the gene. Primers were designed following manufacturer instructions for TOPO 
cloning, into the pET-200 vector from Invitrogen and were obtained from Integrated 
DNA technologies (Table 1)
20, 21
. Genomic DNA, serve as template for amplification of 
target gene was isolated from wild type B.subtilis 168 (BS 168) cells using the Wizard® 
Genomic DNA Purification Kit (from Promega) following manufacturer instructions (Cat 
# A1120).  
 
Table 1: Details about specifications of the mmgB gene primers 
  Parameters Forward  primer Reverse  primer 
    Sequence 5' - cacc atg gaa atc aaa caa atc atg g - 3' 5’ - tca gga agt ctt ctc ctc ata gtc - 3’ 
Tm 55.4⁰C 55.2⁰C 
 
 
The mmgB gene was amplified by a PCR (Polymerase Chain Reaction). The 
components of the PCR included: 25 μL PMM (Phusion master mix), 22 μL Molecular 
Biology Grade Water, 2 μL Genomic (template) DNA, 1.25 μL Forward primer, 1.25 μL 
Reverse primer. PMM is a stock mixture of High Fidelity Phusion Polymerase + Buffer + 
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dNTP’s + counter ions (MgCl2) stored at -20
o
C (from Finzymes/New England Biolabs, 
Cat # F553S).  
PCR amplification of the desired mmgB gene is carried out using a thermocycler, 
according to the following parameters: Initial incubation for 1 minute at 98
o
C followed 
by 25 cycles of each of the; Denaturation for 5 seconds at 98
o
C, Annealing for 1 minute 
at 55
o
C, Extension for 1 minute at 72
o
C. After 25 cycles, an extension cycle for 10 
minutes at 72
o
C is carried out and finally the samples are hold at 4
o
C. 
The PCR product was purified by a QIAquick PCR- purification kit from Qiagen 
(Cat # 28106) following the manufacturer’s specifications
22
. The purified PCR product 
was then analyzed by 1% agarose gel electrophoresis and compared to the 2-log ladder 
base pair standard from New England Biolabs (Cat # N3200S). 
III.A.2. Cloning of the amplified mmgB gene into pET-200 vector 
After the amplification of mmgB was confirmed by agarose gel electrophoresis, 
the PCR amplified mmgB gene was cloned into an expression system. The expression 
system used in our study was the pET200/D-TOPO® vector from Invitrogen (Cat # 
K100-01). The procedure of cloning the amplified mmgB was done following the 
manufacturer instructions
21
.  
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Figure 12: pET 200/D – vector map
21
 (adapted). 
 
 
The plasmid pET200/D-TOPO consists of a kanamycin resistant gene instead of 
ampicillin resistant gene. The target gene(s) was placed under the control of an IPTG 
inducible T7 promoter. A nucleotide sequence corresponding to a 6x His-tag (6 
consecutive histidines) is present in between the T7 promoter and the target gene. This 
set up leads to the production of a recombinant fusion protein with an N-terminal His-tag 
(Figure 12)
21
. 
III.A.3. Transformation and Retransformation of E.coli with cloned pET-200 vector 
Transformation of E.coli with the cloned pET-200 vector (pET-200_mmgB) was 
carried out following the manufacturer’s instructions
21
. Following transformation, the 
cells were spread on LB (Luria-Bertani) – agar plates with 50μg/mL kanamycin and the 
transformants were used to inoculate 5 mL LB with 50 μg/mL kanamycin and incubated 
anaerobically overnight at 37⁰C and 220 rpm.  
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Glycerol (10% v/v) stocks of these cultures were made and stored at -80⁰C for 
further proceedings. Later, overnight liquid cultures of the transformed E.coli cells were 
made by inoculating the antibiotic resistant colonies/cells in 5 mL LB-broth with 
50μg/mL Kanamycin and are grown anaerobically at 37⁰C /220 rpm. The following 
morning, the cloned pET-200 vector (pET-200 vector_mmgB) was isolated from these 
liquid cultures by employing the QIAprep Miniprep kit (Cat # 27106) from Qiagen, 
following the manufacturer instructions
23
. 
A PCR was performed using cloned pET-200 vector (pET-200 vector_mmgB) as 
template DNA and a 1% agarose gel was run to analyze for the presence of insert. The 
isolated, cloned pET-200 vector was stored at -20⁰C for future uses.  
Our next target in line was to transform BL21 (DE3) (a strain of commercially 
available competent E.coli) cells. Competent BL21 cells were obtained from Invitrogen 
and the transformation was achieved following the manufacturer’s instructions. The 
antibiotic selective transformants were picked up and glycerol stocks are made similar to 
how it was done with TOP10 cells
21
. 
Again, cloned pET-200 vector (pET-200 vector_mmgB) was isolated from the 
BL21 cells.  The isolation procedure involves making overnight liquid cultures of the 
transformed BL21 E.coli cells by inoculating the antibiotic resistant colonies/cells in 5 
mL LB-broth with 50μg/mL Kanamycin and growing anaerobically at 37⁰C /220 rpm. 
The following morning, cloned pET-200 vector (pET-200_mmgB) was isolated from 
these liquid cultures by employing the QIAprep Miniprep kit from Qiagen, following 
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manufacturer instructions
23
. The miniprep solution was sent to SeqWright for dye-
terminated DNA sequencing.  
III.B. Overexpression and Isolation of mmgB protein 
For the overexpression of mmgB in BL21 (DE3), 1L cultures were grown by 
inoculating 1L LB-broth (50μg/mL Kanamycin) with 2 mL of an overnight grown starter 
culture of transformed BL21 cells. The growth was monitored spectrophotometrically at 
595nm. When the absorbance (OD595) reached a value between 0.7 – 0.8, IPTG 
(Isopropyl-β-thiogalactopyranoside) was added to the culture to induce overexpression of 
mmgB. IPTG was added to a final concentration of 1mM. Following IPTG addition, the 
culture was left to grow overnight at 37⁰C / 220 rpm allowing for the overexpression of 
the mmgB. 
The following morning, cells from the overnight culture were harvested by 
centrifugation (7500 g, 30 minutes, 4⁰C). The cells were then resuspended in 40 mL 1x 
binding buffer (0.5 M NaCl, 20 mM Tris-HCl, 5 mM Imidazole, pH 7.9). This cell 
suspension was subjected to sonication in order to break open the cells and release 
cellular components. The lysate was then subjected to centrifugation (14,600 g, 30 
minutes, 4⁰C) to remove the cell debris.   
Following centrifugation, the supernatant was further clarified by syringe 
filtration using a 0.45 μm Corning Incorporated Syringe Filter. The crude extract was 
applied to a Ni – NTA column chromatography. This was performed in order to isolate 
the His-tagged mmgB. 
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III.B.1. Ni-NTA Column Chromatography 
The Ni-NTA (nitrolotriacetic acid) column (Cat # 30210) consists of an agarose-
nitrolotriacetic acid resin. The resin is charged with hexadentate Ni
2+
 ions, which are held 
onto the resin by tetra dentate nitrolotriacetic acid molecules (Figure 13)
24
.  
 
 
 
Figure 13: Ni2+-NTA chromatography set-up; his-tag protein interactions with agarose/Ni2+-NTA resin & imidazole 
structure. 
 
 
The crude extract (filtrate) was applied onto the column (column bed volume was 
2 mL) and was allowed to pass through the resin under the influence of gravity. Once all 
the crude extract was run through the column, it was then treated with 10 column 
volumes of 1x binding buffer (0.5 M NaCl, 20 mM Tris-HCl, 5 mM Imidazole, pH 7.9). 
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This was followed by a washing step with 6 column volumes of 1x wash buffer (0.5 M 
NaCl, 20 mM Tris-HCl, 60 mM Imidazole, pH 7.9). Later the column was treated with 6 
column volumes of 1x elute buffer (0.5 M NaCl, 200 mM Imidazole, 20 mM Tris-HCl, 
pH 7.9) to elute the His-tagged protein off the column
24
.  
After isolating the protein to near homogeneity using Ni-NTA column 
chromatography, it was subjected to dialysis. The MWCO (Molecular Weight Cut Off) 
value of the dialysis bag used in our experiments was 7000 Da. For dialysis of the 
protein, we used 4 Liters Tris-HCl, pH 8.0 and the set-up was left undisturbed overnight 
at 4
o
C. Following dialysis, glycerol (10% v/v) stocks of the dialyzed protein were made 
and the aliquots (100μL) were stored at -80
o
C. 
III.C. Characterization of mmgB protein 
III.C.1. SDS-PAGE 
A 12% SDS-PAGE (Sodium Dodecyl Sulfate – Polyacrylamide Gel 
Electrophoresis) was run to confirm the identity of the mmgB protein obtained after 
chromatographic separation. All the eluted fractions, including those of binding & 
washing steps were analyzed. The gel was visualized by Coomassie Blue stain and the 
destaining was achieved, using methanol (30% v/v) and acetic acid (10% v/v). 
III.C.2. Gel-Based Trypsin Digest; MALDI-TOF Mass-Spectrometry 
To reinforce the identity of the protein isolated, MALDI-TOF-MS (Matrix 
Assisted Laser Desorption Ionization – Time of Flight – Mass spectrometry) analyses of 
the gel based trypsin digests of the mmgB protein bands from SDS-PAGE gel were 
performed. Gel based trypsin digestion of the SDS-PAGE bands was achieved by 
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employing the Trypsin Profile IGD kit (Cat # PP0100-1KT) for in-gel digests from 
Sigma-Aldrich. This was performed following the manufacturer instructions. 
III.D. Enzymatic Activity Analyses of mmgB protein 
 
Figure 14: Proposed enzymatic reaction catalyzed by mmgB protein. 
 
 
III.D.1. Determination of appropriate co-factor 
Sets of assays were performed by analyzing the activity with one cofactor (NAD
+
 
or NADP
+
) at a time. We set out to begin with NAD
+
, since it is the most commonly used 
one and also is commercially cheaper than NADP
+
. An initial set of reactions was done 
where the [substrate] and [NAD
+
] or [NADP
+
] were maintained constant but with 
increasing [enzyme]. The buffer employed in the assays was 100 mM potassium-
phosphate buffer, pH 7.3 and the reaction was spectrophotometrically monitored at 340 
nm. The conditions employed are listed in the table below. 
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Table 2: Details of reactions performed with NAD+/NADP
+
 as co-factor. D, L-3-HB-CoA = D, L-3-hydroxybutyryl-CoA 
D,L-3-HB-
CoA 
(mM) 
NAD
+
 
(mM) 
NADP
+
 
(mM) 
Enzyme 
(ng) 
Reaction 
Volume(μL) 
Time 
(min) 
0.2 0.2 0.2 8 500 30 
0.2 0.2 0.2 16 500 30 
0.2 0.2  24 500 30 
0.2 0.2  32 500 30 
0.2 0.2  80 500 30 
 
 
III.D.2. Determination of optimal pH 
We have done many assays by employing different buffers (both composition and 
concentration) and thereby testing the effectiveness of the enzyme at different pH values. 
The different buffers and the pH ranges tested are listed in the table below. The reaction 
mixture contained NADP
+
 as co-factor and was spectrophotometrically monitored at 340 
nm. 
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Table 3: Details about buffers/pH range tested 
 
Buffer used 
 
pH tested 
 
50 mM Na-Phosphate 
 
 
7.3 
 
 
100 mM Na-Phosphate 
 
 
7.3 
 
 
50 mM K-Phosphate 
 
 
7.3 
 
 
100 mM K-Phosphate 
 
 
7.3 
 
 
50 mM Tris 
 
 
7.3 
 
100 mM Tris 
 
7.2 
7.6 
 
100 mM Tris 
8.0 
8.5 
9.0 
9.5 
 
100 mM Glycine-NaOH 
 
 
10.6 
9.8 
 
 
 
III.D.3. Determination of enzymatic activity of mmgB protein 
We started designing experiments which employed NADP
+
 - suitable co-factor, 
Glycine-NaOH buffer pH 9.8 - optimal buffer /pH with varying [substrate], [co-factor] 
and [enzyme] in order to test the enzymatic activity of mmgB. The progress of the 
reactions was spectrophotometrically monitored at 340 nm (λmax of NADPH). Later, 
following spectrophotometric analysis, the reaction mixtures were analyzed by MALDI-
TOF-MS (Matrix Assisted Laser Desorption Ionization – Time of Flight - Mass 
Spectrometry). The table below shows details about the assay conditions employed. 
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Table 4: Details about enzymatic reaction assay conditions 
D,L-3-HB-
CoA 
(mM) 
NADP
+
 
(mM) 
Enzyme 
(ng) 
Buffer 
(μL) 
Reaction 
Volume(μL) 
Time 
(min) 
0.8 0.5 8 431 500 30 
0.8 0.5 16 421 500 30 
0.8 0.5 24 411 500 10 
0.4 0.25 24 440.5 500 30 
0.4 0.25 16 450.5 500 55 
0.4 0.25 24 440.5 500 30 
0.2 0.2 8 467.2 500 20 
0.2 0.2 16 457.2 500 20 
0.2 0.2 24 447.2 500 20 
0.4 0.2 24 434.4 500 15 
0.5 0.2 24 427.9 500 30 
0.4 0.2 32 424.4 500 30 
0.5 0.2 32 417.9 500 30 
 
 
Mass spectrometric analyses were performed to characterize the products of the 
reaction. The MALDI-TOF-MS instrument used was a 4700 Proteomic Analyzer from 
Applied Biosystems (Triad Mass-Spectrometry Laboratory, Department of Chemistry 
and Biochemistry, The University of North Carolina, Greensboro). The samples were 
analyzed with the reflectron in positive ion mode at a fixed laser intensity of 3001. The 
reaction samples were mixed with matrix (10 mg α-cyano-4-hydroxycinnamic acid 
butylamine salt dissolved in 1 mL matrix-A diluent: 50% acetonitrile + 50% nano pure 
H2O + 0.3% trifluoroacetic acid) and matrix-A diluent. Unless otherwise mentioned, all 
the samples were prepared by mixing together matrix: diluent: sample in 40:40:20. = 
III.D.4. Determination of Enzyme kinetics 
Enzymes typically follow Michaelis-Menten kinetics. The kinetic rate constants 
Km app (apparent) of both the substrate (3HBCoA) and co-factor (NADP
+
) were 
determined individually. The Vmax app (apparent) of the reactions was also determined. All 
the reactions for kinetic studies were performed in triplicates. 
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A set of reactions were performed at constant [NADP
+
] and [enzyme] of 0.2 mM 
and 2.0 µM respectively while varying [3-HB-CoA]. The range of [3-HB-CoA] used was 
0.05, 0.1, 0.2, 0.4, 0.6, 0.8, 1.0, 2.0, 3.0 mM. The reactions were performed in Glycine-
NaOH buffer, pH 9.8 and the reaction volume was 500 μL. The reactions were 
spectrophotometrically monitored at 340 nm (λmax of NADPH) and initial velocities of 
the reactions were recorded.  
The initial velocities versus [3-HB-CoA] were plotted with the aid of Slide Write 
software. These plots were then used to calculate Km app of the substrate and Vmax app of 
the reaction.  
Another set of reactions were performed at constant [3-HB-CoA] and [enzyme] of 
0.4 mM and 24 ng respectively while varying [NADP
+
]. The range of [NADP
+
] used was 
0.05, 0.1, 0.2, 0.4, 0.6, 0.8, 1.0, 2.0, 3.0 mM. The reactions were performed in Glycine-
NaOH buffer, pH 9.8 and the reaction volume was 500 μL. The reactions were 
spectrophotometrically monitored at 340 nm (λmax of NADPH) and initial velocities of 
the reactions were recorded.  
Later, graphs were plotted for initial velocities versus [NADP
+
] with the aid of 
‘slide write’ software. These plots were then used to calculate Km app of the co-factor 
(NADP
+
) and Vmax app of the reaction. 
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CHAPTER IV 
RESULTS / DISCUSSION 
IV.A. Cloning of the mmgB gene 
IV.A.1. PCR-amplification of mmgB gene 
The mmgB gene from Bacillus subtilis 168 was amplified by PCR (Polymerase 
Chain Reaction). In order to test for the success of PCR, the PCR amplified product was 
first purified by a PCR purification step following the completion of PCR. The purified, 
amplified mmgB gene was then analyzed by 1% agarose gel electrophoresis, which is 
shown in Figure 15. 
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Figure 15: Agarose gel showing molecular weights standard (L), No DNA control (C), PCR product (P). 
 
 
The agarose gel picture (Figure 15) shows three lanes labeled as L, C, and P. The 
lane L corresponds to 2-log ladder which serves the purpose of a molecular marker. The 
bands seen in the lane L are considered as standards in order to characterize the bands of 
unknown sizes (number of base pairs) appearing in the gel.  
The lane C corresponds to a control reaction with respect to the amplification of 
mmgB gene. The control reaction includes all the PCR components (PMM, primers and 
H2O) except for template DNA. So, the mmgB gene should not amplify as there is no 
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template to direct its amplification. Hence, there should not be any band seen in the lane 
C.  This is in good agreement, as there is no band visible on the gel in the lane 
corresponding to C. This can be used as a negative reference for the success of PCR-
amplification of mmgB gene. 
The lane P corresponds to PCR amplified product which in this case is the 
amplified mmgB gene. This reaction involves all the PCR components including the 
template DNA (genomic DNA from Bacillus subtilis 168) which directs the amplification 
of mmgB gene. Hence there should be a band seen on the gel in lane P corresponding to 
the size of mmgB gene in terms of number of base pairs (bp’s).  
The gel indeed has a band in the lane P which lies at a position in between 0.8 – 
0.9 kilo bases (kb) in comparison to molecular marker seen in the lane L. This is in good 
agreement with the expected size of mmgB gene which is 864 bp’s. So, the result is 
suggestive that mmgB gene was successfully amplified by a PCR.  
IV.A.2. Cloning of amplified mmgB gene into pET-200 vector 
After confirming the successful PCR amplification of the mmgB gene, it was then 
cloned into the pET-200 vector according to the manufacturer instructions. The map for 
pET-200 vector (Figure 16) below shows the cloning site of mmgB insert into the vector. 
The pET-200 vector follows topoisomerase-dependent ligation and hence did not require 
the usual restriction digest and DNA ligase procedure. 
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Figure 16: Cloning of mmgB insert into pET-200 vector
21
 (adapted). 
 
 
IV.A.3. Transformation and Retransformation of E.coli with cloned pET-200 vector 
Following the completion of cloning, One Shot® TOP10 Chemically Competent 
E.coli cells were transformed with the TOPO reaction mixture (pET-200 vector_mmgB). 
Later, the transformed TOP10 E.coli cells were spread on LB – agar plates with 50μg/mL 
Kanamycin for antibiotic resistance selection. Later, the plasmid was screened for mmgB 
by PCR.  
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Figure 17: Agarose gel showing molecular weights standard (L), PCR product amplified using BS168 DNA (C+), PCR       
product amplified without employing BS168 DNA (C-), 1/2/3=PCR product amplified using pET-200 vector_mmgB 
DNA from TOP 10 cells. 
 
 
The agarose gel picture (Figure 17) contains 6 lanes labeled as L, C+, C-, 1, 2, 
and 3. The lane L corresponds to the 2-log ladder; it serves the purpose of a molecular 
marker. The bands seen in the lane L are considered as standards for characterizing the 
bands of unknown sizes (number of base pairs) present on the gel.  
The lane C+ corresponds to a positive control reaction with respective to 
amplification of the mmgB gene. The C+ reaction include all the PCR components (PMM, 
primers, template DNA and H2O). The template DNA is genomic DNA from Bacillus 
subtilis 168. This directs the amplification of mmgB gene. Hence there should be a band 
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seen on the gel in lane C+ corresponding to the size of mmgB gene with reference to 
number of base pairs (bp’s). This is in good agreement with the expected size of mmgB 
gene; 864 bp’s. This was used as a positive reference for amplification of mmgB gene. 
The lane C- corresponds to a negative control reaction with respective to 
amplification of the mmgB gene. The reaction components of the C- reaction include all 
the PCR components (PMM, primers and H2O) except for template DNA. So, the PCR 
should not amplify anything as there is no available template. Hence there should not be 
any band seen in the lane C-.  This is in good agreement as there is no band visible on the 
gel in the lane corresponding to C-. This was used as a negative reference for 
amplification of the mmgB gene, and showed that PCR for mmgB will be successful only 
when the mmgB is available in the reaction.  
The lanes 1, 2 and 3 correspond to PCR reaction with three different plasmids 
obtained from the TOPO cloning transformants. The components of this reaction include 
all the PCR components including the template DNA (pET-200 vector_mmgB) instead 
of genomic DNA, which directs the amplification of mmgB gene. If the pET-200 vector 
possessed the mmgB insert, there should be a band seen on the gel in lanes 1, 2 & 3 
corresponding to the size of mmgB gene with reference to number of bp’s.  
Looking at the gel, there are bands seen in the lanes 1, 2 and 3 lying at a position 
in between 0.8 – 0.9 kb in comparison to molecular marker in the lane L. These bands 
from lanes 1, 2 & 3 align pretty well with the band from the lane C+ in terms of the 
position. The positions of the bands from lanes C+, 1, 2 and 3 are in good agreement with 
the expected size of mmgB gene (864 bp’s). So, the result is suggestive that mmgB gene 
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was successfully cloned into the pET-200 vector and also the cloned pET-200 vector was 
stable in the TOP10 E.coli cells. 
Later, BL21 (DE3) cells were transformed using the cloned pET-200 vector. 
BL21 (DE3) cells were specifically meant for heterologous expression of the target gene, 
which in our case is mmgB. The transformed BL21 cells were spread on LB – agar plates 
with 50μg/mL Kanamycin to grow. Later, the cloned pET-200 vector was isolated from 
antibiotic selective transformants. Following this, a PCR was performed using the cloned 
pET-200 vector (pET-200 vector_ mmgB) as template DNA.   
 
40 
 
 
Figure 18: Agarose gel showing molecular weights standard (L), PCR amplified product usingBS168 DNA (C+), PCR 
amplified product by employing pET-200 vector_mmgB from BL21 (1). 
 
 
In the gel picture above (Figure 18), C+ lane corresponds to a positive control 
reaction with regard to amplification of the mmgB gene. It includes all the PCR 
components wherein genomic DNA from Bacillus subtilis 168 (BS168) was used as the 
template DNA. The lane 1 corresponds to PCR amplified mmgB. It included all the PCR 
components wherein the cloned pET-200 vector (pET-200 vector_mmgB) was used as the 
template DNA. Looking at the bands in the lanes C+ and 1, they lie at a position in 
between 0.8 – 0.9 kb in comparison to molecular marker in the lane L. The positions of 
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these bands are in good agreement with the expected size of mmgB gene (864 bp’s). Also, 
these bands align well with bands from previous gels in terms of the number of base 
pairs. So, the result is suggestive that the cloned pET-200 vector was stable in BL21 
cells. 
The plasmid was sequenced and below shown (Figure 19) is the alignment of the 
mmgB insert sequenced from the cloned pET-200 vector and the mmgB gene sequence 
from the updated genome database. During sequencing, as the reaction reaches the end, 
the sensitivity, i.e. the ability to get the sequence information, decreases. Hence, we see 
some mismatches or dots or sometimes the nucleotides themselves found missing 
towards the end of the sequencing reaction with both the sequencing primers. However, it 
should not be a major concern, since the other strand which primes in opposite direction 
gets the missing sequence information.   
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Figure 19: Alignments of mmgB insert in pET-200 vector and actual, new mmgB gene sequences. 
 
 
IV. B. Overexpression and Isolation of mmgB protein 
With successful completion of cloning, our next goal was to over-express mmgB 
for over-production of the corresponding protein (MmgB). For this purpose, large 
volumes (1L) of cultures were grown. The presence of antibiotic in the culture allowed 
for the selective growth of transformants only. Addition of IPTG to the culture induces 
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overexpression of mmgB. This is because the mmgB insert in pET-200 vector is under the 
control of a T7 promoter present in the vector i.e., a transcriptional fusion is constructed 
(Figure 20). Consequently, the transcriptional activity of the mmgB gene is under the 
control of T7 promoter. 
The T7 promoter is highly specific and is recognized only by T7 RNA 
polymerase. But the pET-200 vector lacks the gene for T7 RNA polymerase. Hence, 
BL21 (DE3) cells were used for propagation of the vector and subsequent over 
expression of the mmgB (Figure 20).   
 
 
 
Figure 20: Mechanism of over expression system
21
. 
 
 
BL21 (DE3) is a mutated strain of E.coli (lysogen of bacteriophage λDE3), which 
contains the T7 RNA polymerase encoding gene but, under the control of the lac 
promoter. The BL21 genome contains the lacI gene which encodes the lac repressor 
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protein that binds to the lac operator and inhibits the transcriptional progress of T7 RNA 
polymerase gene under the control of the lac promoter. Hence, to overcome this 
inhibition due to the lac repressor, IPTG, a molecular mimic of allolactose which is the 
substrate for lac repressor, is added. IPTG binds to the lac repressor protein and 
inactivates it, thereby allowing for the expression of T7 RNA polymerase. Thus owing to 
the accessibility of the lac  promoter, the T7 RNA polymerase produced then binds to the 
T7 promoter present in the vector and initiates the transcriptional activity of downstream 
genes, which in our case is mmgB. Thus, the over expression of the mmgB is achieved via 
the addition of IPTG (Figure 20)
21
. 
IV.B.1. Ni-NTA Column Chromatography 
Following overexpression of the mmgB, our next goal was to isolate the protein to 
near homogeneity. To do so, we employed Ni-NTA column chromatography as a 
separation technique. The reason for using this chromatographic technique is our protein-
mmgB is a recombinant fusion protein with an N-terminal 6x His-tag (6 consecutive 
histidines) owing to the presence of the corresponding nucleotide sequence from the pET-
200 vector. As shown in Figure 13, the Ni-NTA column consists of an agarose-
nitrolotriacetic acid resin charged with hexadentate Ni
2+
 ions held onto the resin by tetra 
dentate nitrolotriacetic acid molecules. When applied, the His-tag protein(s) bind to the 
remaining two coordination sites of Ni
2+
. Thus, this method helps in isolating the target 
protein(s)
21, 24
. 
After the column is equilibrated, the crude extract (filtrate) was applied onto the 
column and allowed to pass through it under the influence of gravity. Once all the crude 
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extract was run through the column, the desired 6x His-tag protein was bound to the Ni
2+
 
ions in the column. 
The column was then treated with buffers having increasing amounts of 
imidazole. Binding buffer (5 mM imidazole) allows the His-Tag protein to bind to resin 
tightly while the wash buffer washes away the undesired proteins. This is possible 
because, wash buffer (60 mM imidazole) has high concentrations of imidazole which 
mimics the histidine residues of the proteins and these compete with the His-tag protein 
for the Ni²
+
 ions present in the agarose bed. This competition causes the proteins without 
His-tag to get washed off the column due to weak interactions with agarose/Ni
2+
 ions 
leaving His-tag proteins only
24
.  
With only His-tagged protein bound to the resin, it was eluted from the column 
using elute buffer with even higher concentrations of Imidazole (200 mM). This high 
concentration of Imidazole disrupts the interactions between the agarose/Ni
2+
 and 6x 
histidines of the His-tag protein and causes the His-tag protein to elute off the agarose 
bed of the column
24
. 
IV.C. Characterization of mmgB protein 
IV.C.1. SDS-PAGE 
Following the isolation process, samples of the protein were analyzed by 12% 
SDS-PAGE (Figure 21) to confirm the identity of the mmgB protein obtained after 
chromatographic separation.  
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Figure 21: 12% SDS-PAGE gel of mmgB protein before Dialysis. 
 
 
The SDS-PAGE gel picture (Figure 21) shows lanes labeled as ladder, crude 
extract, binding buffer, wash buffer and elute: 1
st
, 2
nd 
mL, etc. The lanes ladder 
corresponds to the 10-log protein ladder which served as a molecular weights standard. 
The bands seen in the lanes ladder are considered as standards with reference to 
characterizing the bands of unknown molecular weights (in kDa) seen on the gel.  
The lane crude extract corresponds to the flow through collected after allowing 
the crude extract to pass through the column. This shows many different bands 
representing various proteins expressed during the life time of BL21 cells. In the lane 
crude extract, alongside the various bands, a light band at slightly above 30 kDa was also 
seen. This is consistent with theoretical mass of the mmgB protein: 31.3 kDa
25
. This 
shows that, mmgB is also expressed. The lanes binding buffer and wash buffer show no 
bands at about 30 kDa in reference to ladder and this is suggestive that the actual his-tag 
protein mmgB was still bound to the column. 
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Out of the lanes corresponding to elute buffer -1
st
, 2
nd 
mL, the lane corresponding 
to 1
st
 mL did not show any band at about 30 kDa corresponding to mmgB protein. 
However, each of the lanes corresponding to the 2
nd
 through 5
th
 mL of the elute buffer 
showed a band at slightly above 30 kDa which is consistent with the theoretical mass of 
the mmgB protein, 31.3 kDa.  
Hence, looking at the bands on the gel (Figure 21), it is evident that we achieved 
the purification of a protein having a mass consistent with the desired MmgB protein. 
This result is suggestive that over-expression and isolation processes were successfully 
accomplished. 
IV.C.2. Gel-Based Trypsin Digest; MALDI-TOF Mass-Spectrometry 
To reinforce the identity of the mmgB protein, MALDI-TOF- MS analyses of in-
gel trypsin digests of the bands from SDS-PAGE (Figure 21) were performed. When the 
gel band pieces were incubated with Trypsin, it cleaved the mmgB protein into smaller 
fragments. Each of these tryptic fragments have specific mass values based on their 
amino acid composition. When mass-spectrometric analysis is carried out, the mass 
spectrum showed peaks at the m/z corresponding to the m/z of each of the tryptic 
fragments (experimental values). The theoretical m/z of tryptic fragments for any protein 
can be calculated either manually or can be obtained by making use of online tools 
available such as Peptide Mass 
26
. 
Below are shown the MALDI-TOF-MS spectra (Figures: 22, 23 and 24) for in-gel 
trypsin digests of mmgB protein. The peaks in the mass spectra (spectra are obtained 
from different spots of the MALDI plate but of the same trypsin digest sample) with 
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numerical values correspond to tryptic fragments of mmgB with their respective m/z. To 
make it easier to compare the theoretical values with the experimental values, a table 
listing this data is shown after the MALDI-MS spectra (Table 5).  
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Figure 22: MALDI spectrum (spot-3) of Gel-Based Trypsin Digest of mmgB protein. 
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Figure 23: MALDI spectrum (spot-2) of Gel-Based Trypsin Digest of mmgB protein. 
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Figure 24: MALDI spectrum (spot-1) of Gel-Based Trypsin Digest of mmgB protein. 
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Table 5: Comparison between theoretical and experimental values of the masses of trypsin digest peptides 
Theoretical 
values 
Experimental 
values 
Theoretical 
values 
Experimental 
values 
503 506 1506 1507 
519 515 1598 1599 
587 - 1650 1651 
630 634  1679 
654 - 1847 1849 
705 712  2097 
727 728  2278 
 804 2569 2570 
1016 -  2586 
1049 1050 2895 2896 
 
 
Looking at the numbers between theoretical and experimental values from the 
table above, we can say most of the values are matching. However some of them with 
lower m/z do not match perfectly. Nevertheless, we have a very good confidence about 
the identity of the protein, since the nucleotide sequence of the mmgB insert in the 
plasmid (pET-200_mmgB) was a 100% match with the known mmgB gene sequence.  
At this juncture we do not have a proper understanding of why some of the 
experimental values are off. The possible reasons could be improper calibration of the 
instrument at low m/z range or post-translational modifications of the protein or may be 
the very low concentrations of the protein used.  
Dialysis was performed to remove the excess salts and imidazole present in the 
protein solution, coming from chromatography. Since MWCO of dialysis bag is 7000 Da 
any of the molecules/compounds with MWCO below this value will be separated out of 
the protein solution. 
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Figure 25: 12% SDS-PAGE gel of mmgB protein after Dialysis. 
 
 
Above is shown 12% SDS-PAGE gel picture (Figure 25) shows lanes labeled as 
ladder and dialyzed protein. The lane ladder corresponds to 10-log protein ladder; it 
serves the purpose of a molecular marker. The bands seen in the lane ladder; are 
considered as standards in order to characterize the bands of unknown molecular weights 
(in kDa) seen on the gel.  
Each of the lanes corresponding to dialyzed mmgB protein show a band at 
slightly above 30 kDa which is consistent with the theoretical mass of the mmgB protein 
(31.3 kDa). Also, the position of the bands on the gel is in good compliance with the 
previous SDS-PAGE gel (Figure 21). This is suggestive that we have the right protein 
saved for future experiments, and that dialysis did not result in any undesirable 
decomposition. 
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After doing a general Bradford assay (Figure 26), we found that the yield of 
mmgB protein was 4.0 mg protein produced per liter of the culture of BL21 cells. 
 
 
 
Figure 26: Bradford assay using Bovine Serum Albumin standards. 
 
 
IV.D. Enzymatic Activity Analyses of mmgB protein 
With the protein (mmgB) available in pure form, our next goal was to characterize 
its biochemical activity. 
Based on sequence homology, mmgB is proposed to exhibit 3-Hydroxy-Butyryl-
CoA Dehydrogenase (E.C. 1.1.1.157) activity (Figure 26). Thus, the mmgB protein is an 
Oxido-reductase, catalyzing the oxidation of 3-Hydroxy-Butyryl-CoA (3-HB-CoA) to 
Acetoacetyl-CoA (AcAc-CoA). Homologs of this enzyme have been previously 
characterized from a variety of organisms and have been shown to use either NAD
+
 or 
NADP
+
 as the co-factor
10, 19, 27
. 
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Figure 27: Proposed enzymatic reaction catalyzed by mmgB protein. 
 
 
One of the ways of determining the activity of the enzyme and also the progress 
of the reaction is to spectrophotometrically monitor the increase in absorbance owing to 
reduction of either NAD
+
 or NADP
+ 
to NADH or NADPH respectively at 340 nm (λmax 
of both NADH & NADPH).  
IV.D.1. Determination of appropriate co-factor 
Since no biochemical data is available for mmgB, we did not know the co-factor 
preference, if any of the enzyme. So, we put in our initial efforts in determining the co-
factor preference of the enzyme between NAD
+
 and NADP
+
.  
With NAD
+
, we could never see any significant activity of the enzyme; i.e., there 
was no increase in the absorbance at 340 nm owing to the reduction of NAD
+
 to NADH. 
Hence, the enzyme was not functional with NAD
+ 
as co-factor. This can be seen in the 
UV/Vis-time course shown below (Figure 28).  
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Figure 28: UV/Vis-time course for the reaction with NAD+ as co-factor. 
 
 
On the other hand, the reaction progressed using NADP
+
 as cofactor. With 
NADP
+
, we could see a significant increase in the absorbance at 340 nm owing to the 
reduction of NADP
+
 to NADPH. Hence, the enzyme was specifically functional with 
NADP
+
 only as the cofactor. This can be seen in the UV/Vis-time course shown below 
(Figure 29).  
 
 
Figure 29: UV/Vis-time course for the reaction with NADP+ as co-factor. 
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IV.D.2. Determination of optimal pH 
With the co-factor preference determined, the next task was to determine the pH 
optimum for mmgB. Determining the optimal pH of an enzyme is critical, because pH 
plays a pivotal role in defining the activity of the enzyme. So, one must consider the pH 
aspect when designing an assay for determining the enzymatic activity of a protein. 
The literature shows that, 3-HBDH from Clostridium kluyveri in the acetoacetyl-
CoA (AcAc-CoA) forming direction exhibits maximal activity at a pH between 9.0 and 
10.0 (Figure 30). The enzyme has shown a decreasing trend in terms of its activity out of 
this pH range (9.0-10.0) – both below 9.0 and above 10.0. Similarly, the same enzyme (3-
HBDH) from Clostridium beijerinckiii showed maximal activity in AcAc-CoA forming 
direction at pH 8.0 and the activity decreased when the pH is either increased or 
decreased away from this value. These studies are suggestive that the enzyme in AcAc-
CoA forming direction is active under basic conditions
14, 19, 27
.   
 
 
 
Figure 30: Literature precedent for basic pH dependence of the 3-OH-butyryl-CoA DHase enzyme
27
 (adapted). 
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Based on the precedent from the literature, we looked at buffer solutions whose 
pKa values fall in the basic buffering range of ~8.0-10.0. With Glycine-NaOH buffer at 
pH 9.8, the enzyme showed highest activity (Figure 31). This looked more promising 
upon drawing a comparison between the Figures 29 and 31, since, Figure 29 (pH 7.3) did 
not show much of an increase in the absorbance whereas the Figure 31 (pH 9.8) showed a 
prominent increase in absorbance (1.0000) owing to the formation of NADPH. This fact 
was further supported by our findings about the pH dependence of the enzyme, 3-OH-
Butyryl-CoA-DHase (mmgB). For more details about pH dependent behavior of the 
enzyme, see Figure-55 (supplementary data). 
                
 
 
Figure 31: UV/Vis-time course for the enzymatic activity assay with Glycine-NaOH buffer, pH 9.8. 
 
 
IV.D.3. Determination of enzymatic activity of mmgB protein 
The enzyme has shown maximal activity with the following composition of the 
reaction mixture: 0.4 mM of the substrate - D, L-3-HB-CoA (racemic mixture), 0.2 mM 
NADP
+
, 2.0 µM enzyme and Glycine-NaOH buffer, pH 9.8 with the reaction volume of 
500 μL. 
Upon mixing the components well, we spectrophotometrically monitored the 
reaction at 340 nm. The increase in absorbance showed a nice rectangular hyperbolic 
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curve, indicative of the progression of the reaction via reduction of NADP
+
 to NADPH. 
This can be seen in the UV/Vis-time course shown below (Figure 32).  
Later, following spectrophotometric analysis, the reaction mixture was analyzed 
by MALDI-TOF-MS (Figures 32 and 37). This was performed because the mass 
spectrum of the reaction mixture can show peaks at the m/z corresponding to the 
compounds present in the sample. Based on the m/z values seen, we can determine the 
identity of the compounds present and hence subsequently the identity of the reaction 
itself. 
          
 
 
Figure 32: Spectrophotometric monitoring of the reaction followed by MALDI-TOF-MS analysis. 
 
 
Going with the above mentioned reason, before actually analyzing the reaction 
mixture by mass spectrometry, we instead analyzed a set of standards and control 
reactions using MALDI-TOF MS. Below shown are the MALDI-TOF-MS spectra 
(Figure 33) for standards for the substrate (3-HB-CoA) with m/z of 854, co-factor both 
oxidized (NADP
+
) and reduced (NADPH) forms with m/z of 744 and 746, respectively, 
and the product (AcAc-CoA) with m/z of 852.  
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Figure 33: MALDI-TOF-MS spectra for the standards: substrate, NADP+, NADPH, and product. 
 
 
All the above three spectra pertaining to standards were obtained by employing 
pure compounds. The spectrum for 3-HB-CoA was obtained by doing MALDI-TOF-MS 
analysis of the sample containing only 3-HB-CoA along with matrix and diluent. So, the 
mass spectrum shows a single prominent peak at an m/z of 854 corresponding to the m/z 
of 3-HB-CoA other than the short peaks corresponding to the components of 
matrix/diluent. Similarly, spectra for other standards (NADP
+
, NADPH and AcAc-CoA) 
were also successfully obtained. 
Other short peaks were seen very commonly with no significant abundance value. 
Of these, the peak corresponding to m/z = 768 is the most commonly seen one. It 
corresponds to the mass of CoA (Co-enzyme-A). These (including CoA) are seen 
consistently all through the MALDI-TOF-MS analyses. CoA- thioesters are labile and so 
3HB-CoA (m/z: 854) 
NADP+ (m/z: 744) 
AcAc-CoA (m/z: 852) NADPH (m/z: 746) 
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it is not surprising to see it repeatedly in various MS-spectra. Na
+
 - adducts will also be 
seen consistently in almost all the spectra. 
The MALDI-TOF-MS spectrum shown below (Figure 34) corresponds to a no-
enzyme (3HB DH) control. A reaction was set up with all other components (substrate 
and co-factor) employed, except for the enzyme. So, there should not be any progress of 
the reaction and consequently no product (AcAc-CoA; m/z = 852) formation. Also the 
co-factor NADP
+
 will not undergo reduction to NADPH (m/z = 746). Thus, the mass-
spectrum shows peaks corresponding to only the substrate (m/z = 854) and co-factor 
(NADP
+
; m/z = 744). Figure 54 (supplementary data), corresponds to the UV/Vis – time 
course for no enzyme control. 
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Figure 34: MALDI-TOF-MS spectrum for no enzyme control. 
 
 
The MALDI-TOF-MS spectrum shown below (Figure 35) corresponds to the no-
substrate control (3-HB-CoA; m/z = 854). A reaction was set up with all other 
components (enzyme and co-factor) employed, except for the substrate. So, the reaction 
should not progress and hence has zero product (AcAc-CoA; m/z = 852) formation. Also 
the co-factor NADP
+
 will not undergo reduction to NADPH (m/z = 746). The mass-
spectrum indeed shows only a single prominent peak (m/z =744) corresponding to the co-
NADP+ (m/z: 744) 
3HB-CoA (m/z: 854) 
CoA  (m/z: 768) 
[CoA-Na+] (m/z: 790) 
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factor (NADP
+
) alone. Figure 53 (supplementary data), corresponds to the UV/Vis – time 
course for no substrate control. 
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Figure 35: MALDI-TOF-MS spectrum for no substrate control. 
 
 
The MALDI-TOF-MS spectrum shown below (Figure 36) corresponds to a no-
cofactor control (NADP
+
; m/z = 744). A reaction was set up with all other components 
(enzyme and substrate) of the reaction except for the co-factor (NADP
+
). So, the reaction 
should not progress and hence not form product. Also formation of NADPH (m/z = 746) 
NADP+ (m/z: 744) 
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will not occur. Subsequently, the mass spectrum shows only a single prominent peak 
(m/z =854) corresponding to the substrate (3-HB-CoA) alone. Figure 52 (supplementary 
data), corresponds to the UV/Vis – time course for no cofactor control. 
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Figure 36: MALDI-TOF-MS spectrum for no co-factor control. 
 
 
3HB-CoA (m/z: 854) 
CoA (m/z: 768) 
[CoA-Na+] (m/z: 790) 
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With the standard and control reactions been performed, we now have an idea of 
peaks (m/z) corresponding to the compounds that we expect to see with the full reaction. 
So, with full reaction if we see peaks (m/z) corresponding to NADPH and AcAc-CoA, it 
then explains that mmgB indeed encodes for 3-Hydroxybutyryl-CoA-Dehydrogenase 
(3HBDH).  
The MALDI-TOF-MS spectrum shown below (Figure 37) corresponds to the full 
reaction. A reaction was set up with all the components (enzyme, substrate and co-factor) 
of the reaction. So, the reaction should progress, leading to the formation of product 
(AcAc-CoA; m/z = 852) and also NADPH (m/z = 746). The mass-spectrum indeed 
shows peaks corresponding to the product (AcAc-CoA; m/z = 852) and reduced form of 
the co-factor (NADPH; m/z = 746) alongside the peaks pertaining to both the substrate 
(3-HB-CoA; m/z = 854) and the oxidized form of the co-factor (NADP
+
; m/z = 744) 
indicating the remnants of the substrates. 
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Figure 37: MALDI-TOF-MS spectrum for full reaction. 
 
 
The above shown MALDI-TOF-MS spectrum (Figure 37) shows peaks 
corresponding to the product (AcAc-CoA; m/z = 852) and reduced form of the co-factor 
(NADPH; m/z = 746), it is evident that the reaction has actually progressed and it is 
because of the catalytic activity of the enzyme with the involvement of both the substrate 
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and the co-factor. This fact can further be complemented upon overlapping the MALDI-
TOF-MS spectra of the controls/standards over that of the full reaction. 
IV.D.4. Determination of Enzyme kinetics 
After establishing the optimum assay conditions for monitoring the activity of the 
enzyme, we next moved on determining the kinetic rate constants of the enzymatic 
reaction using Michaelis-Menten kinetics model. The kinetic rate constants Km app 
(apparent) of both the substrate (3HBCoA) and co-factor (NADP
+
) were determined 
individually. The Vmax app (apparent) of the reactions was also determined (Figures 38 and 
39). 
The Km app for substrate (3-HB-CoA) was determined to be 300 µM and the Vmax 
app of the reaction was shown as 110 µM/s. The turn over number kcat of enzyme was 
calculated to be 55 s
-1
 of enzyme. The catalytic efficiency of the enzyme kcat/Km was 0.2 
µM
-1
 . s
-1
. 
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Figure 38: Michaelis-Menten kinetics of the reaction: 3-HB-CoA. 
 
 
The Km app for co-factor (NADP
+
) was determined to be 200 µM and the Vmax app 
of the reaction was shown as 800 µM/s. The turn over number kcat of enzyme was 
calculated to be 400 s
-1
 of enzyme. The catalytic efficiency of the enzyme kcat/Km was 2.0 
µM
-1
 . s
-1
. 
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Figure 39: Michaelis-Menten kinetics of the reaction: NADP+. 
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CHAPTER V 
CONCLUSIONS / FUTURE WORK 
 
 
So far, we successfully cloned the corrected version of the mmgB gene (864 bp’s) 
into a suitable expression system using TOPO cloning methodology. Thereafter we 
successfully over-expressed the mmgB protein by employing BL21 (DE3) strain of E.coli 
cells in an IPTG in dependent manner. Later the N-terminal 6x his-tag recombinant 
fusion protein - mmgB was successfully isolated by employing Ni
2+
 - NTA column 
chromatography and dialyzed. With the aid of 12% SDS-PAGE, Trypsin-digest/MALDI-
TOF-MS analysis (less confident) and Nucleotide sequencing (100% identical), we were 
able to prove the identity of the mmgB protein with reference to theoretical details in 
terms of molecular weight and DNA sequence.  
Later by pursuing enzymatic activity assays with the aid of a UV/Vis 
spectrophotometer and MALDI-TOF-MS, we could confidently conclude that mmgB 
gene encodes for 3-HydroxyButyryl-CoA-Dehydrogenase, which catalyzes the oxidation 
of the 3-hydroxybutyryl-CoA to acetoacetyl-CoA. The analyses also showed that the 
optimal pH for the enzyme was 9.8 (Glycine-NaOH buffer) and it is specific for NADP
+
. 
Thus the above mentioned analyses conclude the fact that, mmgB protein operates as a 
NADP
+
 dependent 3-HydroxyButyryl-CoA-Dehydrogenase.  
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Coming to the future work: the first and foremost on the priority list is physically 
characterizing the mmgB protein i.e., to determine its native molecular weight and 
subunit composition.  In the near future, we would want to pursue experiments for 
characterizing the stereospecificity and the acyl chain length specificity including methyl 
branching tolerance of the enzyme.  
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CHAPTER VI 
 
GENETIC EVIDENCE FOR THE METHYLCITRIC ACID CYCLE IN 
B.SUBTILIS 
 
 
VI.A. Hypothesis/Goals 
Bacillus subtilis is a model organism for studying sporulation. Sporulation is 
controlled by several genes and operons in association with various DNA binding 
proteins and RNA polymerase sigma (σ) factors
3
. The mmg operon is one such operon 
under the control of σ
E
 factor. The mmg operon becomes metabolically active during 
intermediary stages of sporulation. There are a total of 6 open reading frames (ORF’s) in 
the mmg operon – mmgA, B, C, D, E and yqiQ
10
. The downstream 3 ORF’s of the mmg 
operon – mmgD, mmgE and yqiQ are proposed to encode for the methylcitric acid cycle. 
Also, as a part of Master’s thesis (Rejwi Acharya), it has been shown by the Reddick lab 
that mmgD encodes for a citrate/methylcitrate synthase with a substrate preference for 
propionyl-CoA over acetyl-CoA
15
. This fact encouraged us even more with reference to 
involvement of mmg operon in the methylcitric acid cycle, a pathway for propionate 
metabolism. For more details of this pathway, see Chapter ID. 
Our goal was to show physiological evidence for this methylcitric acid cycle. To 
do this, we sought to create conditional knockout mutants of the mmg operon (Figures 40, 
41, 42 and 43) and study the growth characteristics of the organism by feeding studies 
using 
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propionate as the sole carbon source. To be more specific, we wanted to create 2 sets of 
mutants for these studies:  
1) We wanted to place the mmgD, mmgE and yqiQ genes under an IPTG inducible 
 
       Pspac promoter. This comprises the first set of mutants (Figures 40 and 41).  
 
 
 
Figure 40: mmgD mutant design. 
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Figure 41: Cloning of mmgC insert into pMUTIN-4 and the integration of cloned pMUTIN-4 owing to a homologous 
recombination event. 
 
 
2) Whereas with the second set of mutants we wanted to place the whole mmg 
operon (mmgA, B, C, D, E  and yqiQ genes) under the control of IPTG inducible 
Pspac promoter (Figures 42 and 43). 
 
75 
 
 
Figure 42: mmgO mutant design. 
 
Figure 43: Cloning of mmgO insert into pMUTIN-4 and the integration of cloned pMUTIN-4 owing to a homologous 
recombination event. 
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The whole idea for creating conditional knock-out mutants (Figures 41 and 43) 
owing to the insertional mutagenesis is to show that the genes mmgD, mmgE and yqiQ 
are responsible for operating the methylcitric acid cycle in B. subtilis as a means of 
propionate metabolism. This fact can be proved by characterizing the enzymatic activities 
of each of the corresponding genes at the biochemical level. However, to definitively 
assign the physiological roles of the genes, it is of utmost importance to show the 
physiological significance of the same genes on the physiology of the associated 
cell/organism. 
Very often, in order to assign physiological roles of the uncharacterized genes, 
knock-out mutants of the desired genes are created and the result is analyzed. This is a 
very general and straight-forward method that has been practiced for a very long time. 
But, this same strategy cannot be applied to our hypothesis about mmg operon, because 
members of the mmg operon are normally not turned on until late stages of the growth in 
the cultures and hence the regular knock-out mutation strategy won’t work. So, by 
creating a conditional knock-out mutant via insertional mutagenesis (Figures 41 and 43) 
that has the members of the mmg operon placed under the control of an inducible (IPTG) 
promoter (Pspsac) it will allow us to explore the physiology of these genes (mmgD, 
mmgE and yqiQ) without the delays such as waiting till the late growth stages.  
The process of insertional mutagenesis to create conditional knock-out mutants of 
a particular gene or an operon can be performed with the aid of the specially designed 
plasmids. pMUTIN-4 is one of those plasmids (Figure 44). Hence we used pMUTIN-4.  
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Figure 44: Map of pMUTIN-4
2
 (adapted). 
 
 
pMUTIN-4: 
 The intention was to use this for the insertional mutagenesis. Since, 
pMUTIN-4 is a plasmid created to systematically study uncharacterized 
genes in B.subtilis via insertional mutagenesis (Figure 44)
2
. 
 pMUTIN-4 has ColE1, an origin of replication specific for E.coli with 
selection for ampicillin resistance gene but lacks an origin of replication 
for B.subtilis. However pMUTIN-4 bears an erythromycin resistance gene 
that would provide selection if the plasmid integrates into the 
chromosomal DNA of B.subtilis. Hence the only way for B.subtilis to 
benefit from the antibiotic resistance gene in pMUTIN-4 is to integrate the 
plasmid into its genome by homologous recombination (Figures 41, 43 
and 45)
2
. 
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 pMUTIN-4 bears a Multiple Cloning Site (MCS). Also contains an IPTG 
inducible pSPAC promoter which functions in B.subtilis and a lacI gene 
modified to be constitutively express in B.subtilis so that pSPAC promoter 
is turned off when there is no IPTG. pMUTIN-4, it also contains lacZ 
reporter gene and the transcriptional terminators to block the read through 
transcription (Figure 44)
2
. 
 
 
Figure 45: Homologous recombination event
2
 (adapted). 
 
 
Later, after successfully accomplishing the transformation we sought to perform 
feeding studies of the mutants by feeding them with propionate as sole carbon source and 
monitoring their growth characteristics. Eventually, we would also want to do some 
79 
 
NMR analysis of the cultures of the mutants for the intermediates of methylcitric acid 
cycle/propionate metabolism.   
VI.B. Experimental section 
VI.B.1. PCR-amplification of mmgC/mmgO inserts 
Both forward and reverse primers for mmgC/mmgO inserts were designed 
individually in order to amplify the mmgC/mmgO inserts. The mmgC primers were 
designed in the mmgC gene region, ~ 350 bp’s upstream of the mmgD gene, since, our 
intention was to keep mmgD, mmgE and yqiQ genes under the control of an IPTG 
inducible Pspac promoter. However the primers for mmgO were designed in the mmgO 
region itself since we wanted to place the complete mmg operon under the control of an 
inducible promoter.  
Primers were designed using the software, Bio-Edit from North Carolina State 
University and were obtained from Integrated DNA technologies
20
. The primers were 
designed such that the restriction sites were included within them. The forward primer 
(Up primers) for both mmgC and mmgO inserts had HindIII restriction sites. The reverse 
primer (Dn primers) for both mmgC and mmgO inserts had a SacII restriction site. For 
more details, see the table below (Table 6). Genomic DNA which serves as template for 
amplification of target gene fragments is isolated from wild type B.subtilis 168 (BS 168) 
cells using the Wizard® Genomic DNA Purification Kit (from Promega, Cat # A1120) 
following manufacturer instructions.  
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Table 6: PCR primers for mmgO/mmgC inserts 
Primer Sequence Tm (
o
C) 
mmgO_forward 5’ACTGAAGCTTATGAGGAACGGTTTGA 3’ 60.8 
mmgO_reverse 5’AGACCGCGGTTACAATTTCTAGTTGT 3’ 60.1 
mmgC_forward 5’GAAAGAAAGCTTGGGCTTTATGGCTC 3’ 60.2 
mmgC_reverse 5’CAGTTTAGGCCGCGGTTATGAAGG 3’ 60.0 
 
 
The mmgC and mmgO inserts were amplified by a PCR (Polymerase Chain 
Reaction). The components of the PCR included 25 μL PMM (Phusion master mix), 22 
μL Molecular Biology Grade Water, 2 μL Genomic (template) DNA, 1.25 μL Forward 
primer, 1.25 μL Reverse primer. PMM is a stock mixture of High Fidelity Phusion 
Polymerase + Buffer + dNTP’s + counter ions (MgCl2) stored at -20
o
C (from 
Finzymes/New England Biolabs, Cat # F553S).  
PCR amplification of the desired mmgC and mmgO inserts was carried out using a 
thermocycler. Conditions maintained in thermocycler in terms of temperature and time 
periods as shown in Table 7. 
 
Table 7: Conditions maintained in thermocycler 
Parameters mmgO mmgC 
Initial incubation 98
O
 C 1:00 min 98
O
 C 1:00 min 
Denaturation 98
O
 C 0.05 min
 
98
O
 C
 
0.05 min 
Annealing 63
O
 C 1:00 min
 
63
O
 C 0.30 min 
Extension 72
O
 C 1:00 min 72
O
 C 1:00 min 
 
 
After 25 cycles, an extension cycle for 10 minutes at 72
o
C was carried out and 
finally the samples were held at 4
o
C.  
 25 cycles 
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The PCR amplified mmgC and mmgO inserts were purified by a QIAquick PCR- 
purification kit (Cat # 28106) from Qiagen following the manufacturer’s specifications
22
. 
The purified, PCR amplified mmgC and mmgO inserts were then analyzed by 1% agarose 
gel electrophoresis.  
VI.B.2. Cloning of the mmgC/mmgO inserts into the pMUTIN-4 plasmid 
After validation of the amplification of mmgC/mmgO inserts following agarose 
gel electrophoretic analysis, the PCR amplified mmgC/mmgO inserts were subjected to 
restriction digestion using HindIII (from New England Biolabs, Cat # R0104S) and SacII 
(from New England Biolabs, Cat # R0157S) restriction enzymes. Simultaneously, 
pMUTIN-4 was also subjected to restriction digestion using the same set of restriction 
enzymes.  
The eppendorf tubes containing the pMUTIN-4, mmgC and mmgO inserts were 
incubated for 3.5 hours at 37
o
C followed by heat inactivation of the restriction enzymes 
at 65
o
C for 20 minutes. The two restriction enzymes used were HindIII and SacII. Each 
of the three eppendorf tubes contained 2.5 μL New England Biolabs buffer 2, 0.3 μL of 
BSA (Bovine Serum Albumin) stock from New England Biolabs, 1.0 μL each of both the 
restriction enzymes. In addition, 6.0 μL of pMUTIN-4 was added to tube-1, 10.0 μL of 
mmgC insert and 10.0 μL of mmgO insert were added to the tubes 2 and 3 respectively. 
Lastly, molecular biology grade water was added to all the three tubes to a final reaction 
volume of 25 μL.  
All the three restriction digest samples were analyzed by a 1% agarose gel 
electrophoresis. The restriction digested mmgC/mmgO insert and the pMUTIN-4 plasmid 
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bands were cut from the 1% agarose gel and the gel slices were placed in separate 
eppendorf tubes. The mmgC/mmgO insert and pMUTIN-4 plasmid DNA’s were 
recovered from the respective gel slices using QIAquick Gel Extraction Kit (Qiagen, Cat 
# 28706) following the manufacturer’s instructions.  
This was followed up by a ligation procedure which involves ligation of the 
mmgC insert (PCR product) with the vector (pMUTIN-4) and also the ligation of mmgO 
insert (PCR product) with the vector (pMUTIN-4), individually. The ligation was 
achieved using the T4 DNA ligase and ligase buffer from New England Biolabs. Two 
eppendorf tubes were taken and filled with 1 μL T4 DNA ligase, 2 μL ligase buffer and 
11 μL molecular biology grade water. To tube-1, restriction digested mmgC insert and 
pMUTIN-4 plasmid were added in 5:1, whereas to tube-2 restriction digested mmgO 
insert and pMUTIN-4 plasmid were added in 5:1. Finally, the tubes with the ligation 
samples were placed in a thermocycler under the following conditions: for 30 minutes at 
37
o
C, 2 hours at 23
o
C and the samples were held at 16
o
C for overnight.  
VI.B.3. Transformation and Re-transformation of E.coli with cloned pMUTIN-4 
plasmids  
Following cloning of the inserts (both mmgC/mmgO) into the pMUTIN-4 plasmid 
(vector) separately, the cloned plasmids were individually used to transform separate 
batches of NEB-5α strain of competent E.coli cells for propagation purposes. 
NEB-5α strain of competent E.coli cells (Cat # C2992H) were obtained from New 
England Biolabs. Transformation of E.coli with cloned pMUTIN-4 vectors was carried 
out following the manufacturer’s instructions
28
. Following transformation, the cells were 
83 
 
spread on LB (Luria-Bertani) – agar plates with 50μg/mL Ampicillin and the 
transformants were grown in liquid culture supplemented with Ampicillin. 
 Glycerol (10% v/v) stocks of the antibiotic resistant colonies were made and 
stored at -80⁰C for further proceedings. Later, overnight liquid cultures of the 
transformed NEB-5α E.coli cells were made by inoculating the antibiotic resistant 
colonies/cells in 5 mL LB-broth with 50μg/mL Ampicillin and grown anaerobically at 
37⁰C /220 rpm. The following morning, cloned pMUTIN-4 vectors (pMUTIN-4 with 
mmgC insert and pMUTIN-4 with mmgO insert) were isolated from these liquid cultures 
by employing the QIAprep miniprep kit (Cat # 27106) from Qiagen, following the 
manufacturer’s instructions
23
. 
A PCR was performed using cloned pMUTIN-4 vectors (pMUTIN-4 with mmgD 
insert and pMUTIN-4 with mmgO insert) as template DNA and a 1% agarose gel was run 
to analyze for the presence of inserts. The isolated, cloned pMUTIN-4 vectors were 
stored at -20⁰C for future uses.  
Our next target in line was to (re) transform another, fresh batch of NEB-5α cells. 
The transformation was performed as it was done in previous step. The purpose for 
retransformation was to get monoclonal transformants for sequencing. The antibiotic 
selective transformants were picked up and glycerol stocks are made similar to how it 
was done in previous step
28
. 
Again, cloned pMUTIN-4 vectors (pMUTIN-4 with mmgD insert and pMUTIN-4 
with mmgO insert) were isolated, but this time, it was from new batch of NEB-5α 
transformants.  The isolation procedure involves making overnight liquid cultures of the 
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transformed NEB-5α (new batch) E.coli cells by inoculating the antibiotic resistant 
colonies/cells in 5 mL LB-broth with 50μg/mL Ampicillin and growing anaerobically at 
37⁰C /220 rpm. The following morning, cloned pMUTIN-4 vectors (pMUTIN-4 with 
mmgD insert and pMUTIN-4 with mmgO insert) were isolated from these liquid cultures 
by employing the QIAprep miniprep kit (Cat # 27106) from Qiagen, following 
manufacturer instructions
23
. The miniprep solution from NEB-5α (new batch) cells – 
cloned pMUTIN-4 vectors (pMUTIN-4 with mmgD insert and pMUTIN-4 with mmgO 
insert) were sent to SeqWright for getting the sequence information.  
VI.B.4. Transformation of B.subtilis 168 with cloned pMUTIN-4 plasmid  
Our next target was to transform different batches of B.subtilis 168 cells with both 
the cloned pMUTIN-4 plasmids separately. Initially we tried Spizizen natural 
competence/transformation procedures
29
. Competent B.subtilis 168 cells were prepared 
following Spizizen competence induction protocol using minimal media (Spizizen salts). 
Transformation of B.subtilis 168 with cloned pMUTIN-4 vectors was carried out 
following the instructions given in Spizizen procedure. Following the transformation, the 
cells were spread on glucose + minimal salts media – agar plates with 0.3μg/mL 
Erythromycin and the transformants were picked up in antibiotic selective fashion
29
.  
 Later we moved on to pursuing various two-step transformation protocols for 
B.subtilis transformation. The transformation of B.subtilis 168 with cloned pMUTIN-4 
vectors was carried out following the instructions given in two-step transformation 
protocols for B.subtilis transformation. Following transformation, the cells were spread 
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on LB (Luria-Bertani) – agar plates with 0.3μg/mL Erythromycin and the transformants 
were grown in antibiotic selective media
30, 31
.  
VI.C. Results/Discussion 
VI.C.1. PCR-amplification of mmgC/mmgO inserts 
The mmgC and mmgO sections were each amplified from Bacillus subtilis 168 
genome by PCR (Polymerase Chain Reaction). In order to test for the success of PCR, 
the amplified products were first purified by a QIAquick PCR purification step (Qiagen, 
Cat # 28106)
22
. The purified, PCR products were then analyzed by 1% agarose gel 
electrophoresis, as shown in Figure 46.       
                    
 
Figure 46:  1% agarose gels describing the successful amplification of both mmgC/mmgO inserts. 
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Each of the agarose gel pictures (Figure 46) shows 4 lanes labeled as Ladder, 
Control, mmgC (left gel) or mmgO (right gel) and pMUTIN-4. The lane ladder 
corresponds to 2-log ladder from New England Biolabs (Cat # N3200S) and serves the 
purpose of a molecular marker. The bands in the ladder were used as standards in order to 
characterize the bands of unknown sizes (number of base pairs) seen on the gel.  
The control lane corresponds to a control reaction that includes all the PCR 
components (PMM, primers and H2O) except for template DNA. So, the mmgC/mmgO 
inserts should not amplify as there is no template to direct their amplification.  This is in 
good agreement, as there were no bands visible on either gel in those lanes. These show 
that the PCR is dependent on template and that there is no template contaminating the 
PCR components. 
The lane mmgC in the left gel corresponds to the PCR amplified product which in 
this case is amplified mmgC insert. This reaction contains all the PCR components 
including the template DNA (genomic DNA from Bacillus subtilis 168) which directs the 
amplification of mmgC insert. Hence there should be a band seen on the gel in lane 
mmgC corresponding to the size of mmgC insert in terms of number of base pairs (bp’s). 
This lane indeed have a band which lies at a position in between 0.3 – 0.4 kilo bases (kb) 
in comparison to molecular marker seen in the lane L. This is in good agreement with the 
expected size of the mmgC insert which is 341 bp’s. So, the result is suggestive that 
mmgC insert was successfully amplified by a PCR.  
The lane mmgO in the right gel (Figure 46) corresponds to the PCR amplified 
product of the mmgO insert. This reaction contains all the PCR components including the 
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template DNA (genomic DNA from Bacillus subtilis 168) which directs the amplification 
of mmgO insert. Hence there should be a band seen on the gel in lane P corresponding to 
the size of mmgO insert in terms of number of base pairs (bp’s). There is indeed a band in 
the lane mmgO which lies at a position in between 0.2 – 0.3 kilo bases (kb) in comparison 
to molecular marker seen in the lane L. This is in good agreement with the expected size 
of mmgO insert which is 249 bp’s. So, the result is suggestive that the mmgO insert was 
successfully amplified by a PCR.  
The lanes pMUTIN-4 from both the gels (left & right) (Figure 46) corresponds to 
the pure plasmid after miniprep. No PCR was performed for these samples. In these gel 
lanes, there are indeed bands which lie at a position in between 8.0 – 9.0 kilo bases (kb) 
in comparison to molecular marker seen in the lane L.  Since pMUTIN-4 consists of 8610 
bps, the plasmid with which we are working is correct.  
VI.C.2. Cloning of amplified mmgC/mmgO inserts into pMUTIN-4 plasmid 
After confirming the successful PCR amplification of the mmgC and mmgO 
inserts; they were cloned into the pMUTIN-4 vector. The map for pMUTIN-4 plasmid 
(Figure 47) below shows the multiple cloning site of the pMUTIN-4 vector, where the 
mmgC/mmgO inserts are to be cloned. 
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Figure 47: Cloning of mmgC/mmgO inserts into pMUTIN-4 plasmid
2
 (adapted). 
 
 
VI.C.3. Transformation and Retransformation of E.coli with cloned pMUTIN-4 
plasmids 
Following the completion of cloning, NEB-5α E.coli cells were transformed with 
the cloned pMUTIN-4 vector (pMUTIN-4_mmgC and pMUTIN-4_ mmgO). Later, the 
transformed NEB-5α E.coli cells were spread on LB – agar plates with 50μg/mL 
Ampicillin to grow
28
. Due to the presence of antibiotic, only transformants/clones with 
pMUTIN-4 vector inside them will survive, while others simply die because of the 
antibiotics in the media. This antibiotic resistance property of the clones owe to the 
Ampicillin resistance gene present in the plasmid. Later, a PCR was performed to screen 
the isolated pMUTIN-4 vectors (pMUTIN-4_mmgC and pMUTIN-4_mmgO) for 
mmgC/mmgO inserts.   
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Figure 48: 1% Agarose gel analysis after cloning of the mmgC/mmgO inserts into the pMUTIN-4 plasmid. The PCR’s 
were performed using the cloned pMUTIN-4 plasmids (pMUTIN-4 _mmgC, left gel & pMUTIN-4_mmgO, right gel) as 
template DNA. 
 
 
Figure 48 shows the gel picture taken of the PCR screening reactions. The agarose 
gel pictures (Figure 48) contain lanes labeled as 2-log ladder from New England Biolabs 
(Cat # N3200S). This corresponds to the molecular marker. The bands seen in the lane L 
are considered as standards for characterizing the bands of unknown sizes (number of 
base pairs) present on the gel.  
The agarose gel picture on the left shows four lanes with one band in between 0.3 
– 0.4 bp’s.  All the single bands in those lanes correspond to the amplified mmgC insert 
from the PCR using cloned pMUTIN-4 with mmgC insert (pMUTIN-4_mmgC) in as the 
template DNA. The bands are seen at ~350 bp’s which corresponds to the size of the 
mmgC insert, which is expected to be 341 bp’s. This confirms the cloning of mmgC insert 
into all the four pMUTIN-4 plasmids that were isolated. All these four lanes correspond 
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to PCR reactions with four different pMUTIN-4_mmgC plasmids from different NEB-5α 
transformants. 
The agarose gel picture on the right shows four lanes with one band in between 
0.2 – 0.3 bp’s.  All the single bands in those lanes correspond to the amplified mmgO 
insert from the PCR using cloned pMUTIN-4 with mmgO insert (pMUTIN-4_mmgO) in 
as the template DNA. The bands are seen at ~250 bp’s which corresponding to the size of 
mmgO insert. This is in good agreement with the expected size of mmgO insert which is 
249 bp’s. This confirms the cloning of mmgO insert into each of the four pMUTIN-4 
plasmids that were isolated. All these four lanes correspond to PCR reactions with four 
different pMUTIN-4_mmgO plasmids from different NEB-5α transformants. 
The bands on the gels (both left & right) were suggestive of the successful cloning 
of the mmgC/mmgO inserts into the pMUTIN-4 plasmid individually (pMUTIN-4_mmgC 
and pMUTIN-4_mmgO). The positions of the bands from both the gels were in good 
agreement with the expected sizes of the mmgC/mmgO inserts which were 341/249 bp’s 
respectively.  
Later, a new batch of NEB-5α E.coli cells was transformed using cloned 
pMUTIN-4 plasmids (pMUTIN-4_mmgC and pMUTIN-4_mmgO). The purpose for 
retransformation was to ensure we obtained monoclonal plasmids for sequencing. The 
transformed NEB-5α E.coli cells were spread on LB – agar plates with 50μg/mL 
Kanamycin to grow
28
. Later, cloned pMUTIN-4 plasmids were isolated from antibiotic 
selective transformants using a QIAprep miniprep kit from Qiagen
23
. Following this, a 
PCR was performed using cloned pMUTIN-4 plasmids (pMUTIN-4_mmgC and 
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pMUTIN-4_ mmgO) as template DNA.  Both plasmids were sequenced (data not shown), 
the sequences show that the desired constructs were successfully made.  
VI.C.4. Transformation of B.subtilis 168 with cloned pMUTIN-4 plasmid 
We later moved to transformations of different batches of B.subtilis 168 cells with 
both the cloned pMUTIN-4 plasmids (pMUTIN-4_mmgC and pMUTIN-4_mmgO) 
separately. With the Spizizen natural competence/transformation procedures, we got 
some colonies/cells-transformants in antibiotic selective manner owing to the presence of 
the erythromycin-resistance gene present in the pMUTIN-4 plasmid
29
. Later, a PCR was 
used to screen for the mutation (Figures 41 and 43) using the genomic DNA isolated 
from the transformants (mutants) as template DNA. However, the agarose gel pictures 
(Figure 49) below do not show conclusive results with respect to successful 
transformation of B.subtilis 168 and the integration of cloned pMUTIN-4 vectors 
(pMUTIN-4_mmgC and pMUTIN-4_mmgO) in to the B.subtilis 168 chromosomal DNA.  
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Table 8: Details of the primers for cloning and screening 
Primer set Screening for cloning 
(size of the DNA 
fragment) 
Screening for insertional 
mutation (size of the DNA 
fragment) 
mmgC – Up/Dn (in the 
tail end of mmgC gene) 
Yes (341 bp’s) Yes (8610 bp’s + 341 bp’s) 
mmgO - Up/Dn 
 
Yes (249 bp’s) Yes (8610 bp’s + 249 bps’) 
mmgC – Up/Dn (for the 
entire mmgC gene) 
No (1134 bp’s) Yes (8610 bp’s + 1134 bp’s) 
mmgO-Up / yqiQ-Dn 
 
No (6627 bp’s) Yes (8610 bp’s + 6627 bp’s) 
mmgO-Up / mmgA –Dn 
 
No (1428 bp’s) Yes (8610 bp’s + 1428 bp’s) 
mmgD – Up/Dn (for the 
entire mmgD gene) 
No (1116 bp’s) Yes (8610 bp’s + 1116 bp’s) 
mmgC –up / mmgD – 
Dn 
 
No (1457) Yes (8610 bp’s + 1147 bp’s) 
lacI – Up / mmgA - Dn No (PCR product will 
not be obtained) 
Yes (xxxx bp’s) 
lacI – Up / mmgC -Dn No (PCR product will 
not be obtained) 
Yes (xxxx bp’s) 
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Figure 49: 1% Agarose gels for PCR screening analysis of both mmgC/mmgO mutations with Spizizen procedures. 
For more details see the explanation below.    
 
 
The agarose gel pictures (Figure 49) contain lanes labeled as L. This corresponds 
to 2-log ladder, the molecular marker. The bands seen in the lanes L are considered as 
standards for characterizing the bands of unknown sizes (number of base pairs) present 
on the gel. 
The agarose gel picture on the left shows lanes labeled as 1, 2, 3, 4, 5, and 6 with 
a single band in each of the lanes.  The single band in the lane 1 corresponds to the 
amplified mmg operon (mmgA, B, C, D, E and yqiQ genes) after PCR amplification using 
the primer set: mmgO-up and yqiQ-dn with BS 168 genomic DNA as template for PCR 
amplification. The lane 1 shows a band in between 6.0 – 8.0 kb which is consistent with 
the known length of the mmg operon in terms of number of base pairs, 6627 bp’s. This 
can be used as a reference with respect to the size of the mmg operon from mutants after 
PCR amplification (Figure 43). 
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The single band in the lane 2 corresponds to the amplified mmgO insert after PCR 
amplification using the primer set: mmgO-up and mmgO-dn with BS 168 genomic DNA 
as template for PCR amplification. The lane 2 shows a band in between 0.2 – 0.3 kb 
which is consistent with the theoretical length of the mmgO insert in terms of number of 
base pairs, 249 bp’s. This (mmgO amplification from BS168 genomic DNA) can be used 
to compare to the size of the mmgO from mutant (mmgO amplification from mmgO 
mutant genomic DNA, after integration of pMUTIN-4_mmgO) after PCR amplification 
(Figure 43). 
The single band in the lane 3 corresponds to the amplified mmgC insert after PCR 
amplification using the primer set: mmgC-up and mmgC-dn with BS 168 genomic DNA 
as template for PCR amplification. The lane 3 shows a band in between 0.3 – 0.4 kb 
which is consistent with the theoretical length of the mmgC insert in terms of number of 
base pairs, 341 bp’s and is in good agreement with the previous gels from screening after 
PCR amplification. This (mmgC amplification from BS168 genomic DNA) can be used 
to compare to the size of the mmgC from mutant (mmgC amplification from mmgC 
mutant genomic DNA, after integration of pMUTIN-4_mmgC) after PCR amplification 
(Figure 41). 
The single band in the lane 4 corresponds to the amplified lacI gene (present in 
pMUTIN-4) after PCR amplification using the primer set: lacI-up and lacI-dn with DNA 
isolated from the mmgO mutant (pMUTIN-4_mmgO integrated into BS168 chromosome 
= pMUTIN-4_mmgO_BS168) as template for PCR amplification. The lane 4 shows a 
band at about 1000 bp’s which is consistent with the theoretical length of the lacI gene in 
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terms of number of base pairs, 1080 bp’s. This is suggestive that the plasmid integrated 
into the BS 168 genome, since, B.subtilis doesn’t have the lacI gene. But at this point we 
were not sure of location of the plasmid (pMUTIN-4_mmgO) integration into BS 168 
chromosomal DNA (Figures 42 and 43).  
The single band in the lane 5 corresponds to the amplified mmgO insert (cloned 
into pMUTIN-4) after PCR amplification using the primer set: mmgO-up and mmgO-dn 
with DNA isolated from the mmgC mutant (pMUTIN-4_mmgC integrated into BS168 
chromosome = pMUTIN-4_mmgC_BS168) as template for PCR amplification. The lane 
5 shows a band in between 0.2 – 0.3 kb which is consistent with the theoretical length of 
the mmgO insert in terms of number of base pairs, 249 bp’s and is in good agreement (in 
terms of number of bp’s) with the band from lane 2 on the same gel, after PCR 
amplification. This result is conclusive that the mmgO region of the mmg operon is not 
mutated with pMUTIN-4_mmgC. This is a good sign, also, insertional mutagenesis due 
to the cloned plasmid should be site specific (Figures 41 and 43). However the site of 
mutation is not yet revealed. 
The single band in the lane 6 corresponds to the amplified lacI gene (present in 
pMUTIN-4) after PCR amplification using the primer set: lacI-up and lacI-dn with 
mmgC mutant (pMUTIN-4_mmgC_BS168) genomic DNA as template for PCR 
amplification. The lane 6 shows a band at about 1000 bp’s which is consistent with the 
theoretical length of the lacI gene in terms of number of base pairs, 1080 bp’s and is in 
good agreement (in terms of number of bp’s) with the band from lane 4 on the same gel, 
after PCR amplification. This is suggestive that the plasmid is integrated into the BS 168 
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genome, but does not show the location of the integration. The following PCR reactions 
were designed to reveal this location (Figures 41 and 43).  
The agarose gel picture (Figure 49) on the right shows lanes labeled as 7, 8, 9, 10, 
and 11with a single band each in the lanes 9, 10 & 11, but no bands are seen in the lanes 
7, & 8. The lane 7 corresponds to PCR pertaining to the amplification of lacI-up/mmgA-
dn insert using the primer set: lacI-up and mmgA-dn with mmgO mutant (pMUTIN-
4_mmgO_BS168) genomic DNA as template for PCR amplification. The lane 7 shows no 
band at all. This is suggestive that the plasmid did not integrate into the BS 168 
chromosomal DNA in the mmg operon region and the expected mmgO conditional 
mutant (Figure 43) was not created.  
The lane 8 corresponds to PCR pertaining to the amplification of lacI-up/mmgD-
dn insert using the primer set: lacI-up and mmgD-dn with mmgC mutant (pMUTIN-
4_mmgC_BS168) genomic DNA as template for PCR amplification. The lane 8 showed 
no band at all. This was suggestive that the plasmid did not integrate into BS 168 
chromosomal DNA in the mmg operon region and the expected mmgC conditional mutant 
(Figure 41) was not created. 
The lane 9 corresponds to PCR pertaining to the amplification of mmgO -up/ 
mmgA -dn insert using the primer set: mmgO-up and mmgA-dn with mmgO mutant 
(pMUTIN-4_mmgO_BS168) genomic DNA as template for PCR amplification. The lane 
9 shows a band in between 1.2 – 1.5 kb which is consistent with the theoretical length of 
the mmgA gene in terms of number of base pairs; 1182 bp’s. This is again suggestive that 
the plasmid did not get integrated into BS 168 chromosomal DNA in mmg operon region 
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and the expected mmgO conditional mutant is not created. If mutation has happened, 
expected size of the mmgA gene would have been 1182 (mmgA) + 8610 bp’s (pMUTIN-
4) (Figure 43). 
The lane 10 corresponds to PCR pertaining to the amplification of mmgD-
up/mmgD-dn insert using the primer set: mmgD-up and mmgD-dn with mmgC mutant 
(pMUTIN-4_mmgC_BS168) genomic DNA as template for PCR amplification. The lane 
10 shows a band in between 1.0 – 1.2 kb which is consistent with the theoretical length of 
the mmgD gene in terms of number of base pairs; 1137 bp’s. This result is conclusive that 
the mmgD region of the mmg operon is not mutated with pMUTIN-4_mmgC. This is a 
good sign, also, insertional mutagenesis due to the cloned plasmid should be site specific 
(Figure 41). However the site of mutation is not yet revealed. 
The lane 11 corresponds to PCR pertaining to the amplification of mmgO -up/ 
mmgA-dn insert using the primer set: mmgO-up and mmgA-dn with BS 168 (wild type) 
genomic DNA as template for PCR amplification. The lane 11 shows a band at a position 
in between 1.2 – 1.5 kb which is consistent with the theoretical length of the mmgA gene 
in terms of number of base pairs; 1182 bp’s. Since, this PCR amplified product is from 
wild type BS 168; it can therefore be used as a reference with respect to the size in 
comparison to mmgO mutant (Figures 42 and 43).  
At this juncture we understood that the transformation experiments we pursued 
were not successful i.e., the wild type B.subtilis 168 cells did not integrate the pMUTIN-4 
vectors (pMUTIN-4_mmgC and pMUTIN-4mmgO) into the desired locations of the 
genome. Since we were not confident in the Spizizen procedure, which was difficult to 
98 
 
interpret and follow, we moved onto pursuing different two-step transformation 
procedures
30, 31
. Below are shown gel pictures (Figure 50) corresponding to the results 
after the two-step transformation experiments.  
 
 
 
Figure 50: Agarose gels for PCR screening analysis of mmgC mutation with two-step transformation procedures. For 
more details see the explanation below. 
 
 
The agarose gel pictures (both left & right) shown above (Figure 50) correspond 
to the PCR amplified products with respect to mmgC mutants (pMUTIN-
4_mmgC_BS168). The agarose gel pictures contain lanes labeled as L. This corresponds 
to 2-log ladder, the molecular marker. The bands seen in the lanes L are considered as 
standards for characterizing the bands of unknown sizes (number of base pairs) present 
on the gel.  
The agarose gel picture on the left shows lanes labeled as 1, 2, 3, 4, and 5 with a 
single band each in the lanes 1 & 2, but no bands are seen in the lanes 3, 4, & 5.  The 
single band in the lane 1 corresponds to the amplified lacI gene after PCR amplification 
using the primer set: lacI-up and lacI-dn with cloned pMUTIN-4 plasmid (pMUTIN-
4_mmgO) DNA as template for PCR amplification. The lane 1 shows a band at about 1.0 
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kb which is consistent with the theoretical length of the lacI gene in terms of number of 
base pairs, 1080 bp’s. This can be used as a reference with respect to integration of the 
pMUTIN-4_mmgO into the BS168 chromosomal DNA (Figures 43).  
The single band in the lane 2 corresponds to the amplified lacI gene after PCR 
amplification using the primer set: lacI-up and lacI-dn with cloned pMUTIN-4 plasmid 
(pMUTIN-4_mmgC insert) DNA as template for PCR amplification. The lane 2 shows a 
band at about 1.0 kb which is consistent with the theoretical length of the lacI gene in 
terms of number of base pairs; 1080 bp’s. This can also be used as a reference with 
respect to integration of the pMUTIN-4_mmgC into the BS168 chromosomal DNA 
(Figures 41). 
The lane 3 corresponds to the amplified lacI gene after PCR amplification using 
the primer set: lacI-up and lacI-dn with BS 168 (wild type) genomic DNA as template for 
PCR amplification. The lane 3 shows no band at about 1.0 kb corresponding to the length 
of the lacI gene in terms of number of base pairs; 1080 bp’s. This can be used as a 
negative control with respect to the insertional mutation in mmg operon. If mutation does 
occur owing to the integration of the cloned pMUTIN-4 plasmid (pMUTIN-4_mmgC) 
into the chromosomal DNA of BS 168, then upon PCR screening, the agarose gel should 
show a band at exactly the same position (1080 bp’s) as it is seen in lanes 1 & 2. But, if 
mutation does not occur, then no band corresponding to the size of lacI gene would be 
seen on the gel. 
The lane 4 corresponds to the amplified lacI gene after PCR amplification using 
the primer set: lacI-up and lacI-dn with mmgC mutant (pMUTIN-4_mmgC_BS168) 
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genomic DNA as template for PCR amplification. The lane 4 shows no band at about 1.0 
kb corresponding to the length of the lacI gene in terms of number of base pairs, 1080 
bp’s. This is suggestive that the cloned pMUTIN-4 plasmid (pMUTIN-4_mmgC) is not 
integrated into BS168 chromosomal DNA (Figure 41).  
The lane 5 corresponds to the amplified lacI gene after PCR amplification using 
the primer set: lacI-up and lacI-dn with another mmgC mutant (pMUTIN-
4_mmgC_BS168) genomic DNA as template for PCR amplification. The lane 5 shows no 
band at about 1.0 kb corresponding to the length of the lacI gene in terms of number of 
base pairs, 1080 bp’s. This is suggestive that the cloned pMUTIN-4 plasmid (pMUTIN-
4_mmgC) is not integrated into BS168 chromosomal DNA (Figure 41).  
The agarose gel picture on the right shows lanes labeled as 6, 7, 8, and 9 with a 
single band each in the lanes 8 & 9, but no bands are seen in the lanes 6 & 7.  The lane 6 
corresponds to the amplified lacI gene after PCR amplification using the primer set: lacI-
up and lacI-dn with another mmgC mutant (pMUTIN-4_mmgC_BS168) genomic DNA 
as template for PCR amplification. The lane 6 shows no band at about 1.0 kb 
corresponding to the length of the lacI gene in terms of number of base pairs, 1080 bp’s. 
Again, this too is suggestive that the cloned pMUTIN-4 plasmid (pMUTIN-4_mmgC) is 
not integrated into BS168 chromosomal DNA (Figure 41).  
The lane 7 corresponds to the amplified lacI gene after PCR amplification using 
the primer set: lacI-up and lacI-dn with another mmgC mutant (pMUTIN-
4_mmgC_BS168) genomic DNA as template for PCR amplification. The lane 7 shows no 
band at about 1.0 kb corresponding to the length of the lacI gene in terms of number of 
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base pairs 1080 bp’s. This too is suggestive that the cloned pMUTIN-4 plasmid 
(pMUTIN-4_mmgC) is not integrated into BS168 chromosomal DNA (Figure 41). 
However, the strains had erythromycin resistance; so, we do not understand why there 
was no integration. 
The single band in the lane 8 corresponds to the amplified mmgO insert after PCR 
amplification using the primer set: mmgO-up and mmgO-dn with cloned pMUTIN-4 
DNA (pMUTIN-4_mmgO) as template for PCR amplification. The lane 8 shows a band 
in between 0.2 – 0.3 kb which is consistent with the theoretical length of the mmgO insert 
in terms of number of base pairs, 249 bp’s and is in good agreement with the previous 
gels from screening after PCR amplification. This is suggestive that the mmgO insert 
cloned into the Pmutin-4 plasmid used for the transformation was still intact with the 
plasmid (Figure 43).    
The single band in the lane 9 corresponds to the amplified mmgC insert after PCR 
amplification using the primer set: mmgC-up and mmgC-dn with cloned pMUTIN-4 
DNA (pMUTIN-4_mmgD) as template for PCR amplification. The lane 9 shows a band 
in between 0.3 – 0.4 kb which is consistent with the theoretical length of the mmgC insert 
in terms of number of base pairs which is 341 bp’s and is in good agreement with the 
previous gels from screening after PCR amplification. This is suggestive that the mmgC 
insert cloned into the Pmutin-4 plasmid used for the transformation was still intact with 
the plasmid (Figure 41). 
The agarose gel pictures (both left & right) shown below (Figure 51) correspond 
to the PCR amplified products with respect to mmgO mutants. The agarose gel pictures 
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contain lanes labeled as L. This corresponds to 2-log ladder, the molecular marker. The 
bands seen in the lanes L are considered as standards for characterizing the bands of 
unknown sizes (number of base pairs) present on the gel.  
 
 
 
Figure 51: Agarose gels for PCR screening analysis of mmgO mutation with two-step transformation procedures. 
For more details see the explanation below. 
 
 
The agarose gel picture on the left shows lanes labeled as 1, 2, 3, 4, 5, 6 and 7 
with a single band each in the lanes 1 & 2, but no bands are seen in the lanes 3, 4, 5, 6 & 
7.  The single band in the lane 1 corresponds to the amplified lacI gene after PCR 
amplification using the primer set: lacI-up and lacI-dn with cloned pMUTIN-4 plasmid 
(pMUTIN-4_mmgO) DNA as template for PCR amplification. The lane 1 shows a band 
at about 1.0 kb which is consistent with the theoretical length of the lacI gene in terms of 
number of base pairs 1080 bp’s. This can be used as a reference with respect to 
integration of the pMUTIN-4_mmgO into the BS168 chromosomal DNA (Figures 43).  
The single band in the lane 2 corresponds to the amplified lacI gene after PCR 
amplification using the primer set: lacI-up and lacI-dn with cloned pMUTIN-4 plasmid 
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(pMUTIN-4_mmgC) DNA as template for PCR amplification. The lane 2 shows a band 
at about 1.0 kb which is consistent with the theoretical length of the lacI gene in terms of 
number of base pairs 1080 bp’s. This can also be used as a reference with respect to 
integration of the pMUTIN-4_mmgC into the BS168 chromosomal DNA (Figure 41). 
The lane 3corresponds to the amplified lacI gene after PCR amplification using 
the primer set: lacI-up and lacI-dn with BS 168 (wild type) genomic DNA as template for 
PCR amplification. The lane 3 shows no band at about 1.0 kb corresponding to the length 
of the lacI gene in terms of number of base pairs; 1080 bp’s. This can be used as a 
negative control with respect to the insertional mutation in mmg operon. If mutation does 
occur owing to the integration of the cloned pMUTIN-4 plasmid (pMUTIN-4_mmgO) 
into the chromosomal DNA of BS 168, then upon PCR screening, the agarose gel should 
show a band at exactly the same position (1080 bp’s) as it is seen in lanes 1 & 2. But, if 
mutation does not occur, then no band corresponding to the size of lacI gene would be 
seen on the gel. 
The lanes 4, 5, 6, 7, 8 & 9 correspond to the amplified lacI gene after PCR 
amplification using the primer set: lacI-up and lacI-dn with mmgO mutant(s)-1, 2, 3, 4, 5, 
6 (pMUTIN-4_mmgO_BS168) genomic DNA as template for PCR amplification. All 
these lanes (4, 5, 6, 7, 8 & 9) show no band at about 1.0 kb corresponding to the length of 
the lacI gene in terms of number of base pairs 1080 bp’s. This is suggestive that the 
cloned pMUTIN-4 plasmid (pMUTIN-4_mmgO) is not integrated into BS168 
chromosomal DNA (Figure 43).  
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The single band in the lane 10 corresponds to the amplified mmgO insert after 
PCR amplification using the primer set: mmgO-up and mmgO-dn with cloned pMUTIN-4 
(pMUTIN-4_mmgO) DNA as template for PCR amplification. The lane 10 shows a band 
in between 0.2 – 0.3 kb which is consistent with the theoretical length of the mmgO insert 
in terms of number of base pairs 249 bp’s and is in good agreement with the previous 
gels from screening after PCR amplification. This is suggestive that the mmgO insert 
cloned into the Pmutin-4 plasmid used for the transformation was still intact with the 
plasmid (Figure 43). 
The single band in the lane 11 corresponds to the amplified mmgC insert after 
PCR amplification using the primer set: mmgC-up and mmgC-dn with cloned pMUTIN-4 
DNA (pMUTIN-4_mmgC) as template for PCR amplification. The lane 11 shows a band 
in between 0.3 – 0.4 kb which is consistent with the theoretical length of the mmgC insert 
in terms of number of base pairs; 341 bp’s and is in good agreement with the previous 
gels from screening after PCR amplification. This is suggestive that the mmgC insert 
cloned into the pMUTIN-4 plasmid used for the transformation was still intact with the 
plasmid (Figure 41). 
VI.D. Conclusions/Future work 
So, in conclusion, we successfully PCR amplified the mmgO/mmgC inserts and 
cloned them into the pMUTIN-4 plasmid. However, we were not able to transform the 
BS 168 cells with the cloned pMUTIN-4 plasmids, such that this forms the desired 
mutation. 
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 Coming to the future work, the first thing we would want to achieve is to 
determine whether BS 168 cells become competent. Using that critical information we 
would pursue transformation experiments in order to transform BS 168 cells with the 
cloned pMUTIN-4 plasmids. 
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APPENDIX A 
SUPPLEMENTARY DATA 
 
 
 
Figure 52: UV/Vis - time course of no cofactor control. 
 
 
 
Figure 53: UV/Vis - time course of no substrate control. 
 
 
 
Figure 54: UV/Vis - time course of no enzyme control. 
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Figure 55: pH dependence curve of 3-OH-Butryl-CoA-DHase enzyme with glycine-NaOH buffer. 
 
 
 Growth curves of wild type B.subtilis 168  
Since our experiments for transformation of BS 168 with the cloned pMUTIN-4 
plasmids weren’t successful, we were concerned that we were transforming the BS 168 
when they were not competent. So, in an effort to sort out a way for making competent 
cells and subsequently transforming BS 168 cells with the cloned plasmids, we initiated 
growth curves. Literature precedent show that BS 168 cells become naturally competent 
during the transition from exponential to stationary phase (i.e., either in late exponential 
or in early stationary phase)
30, 32
. 
Hence, we started to measured growth curves of the wild type B.subtilis 168. 
Overnight starter cultures of the wild type B.subtilis 168 cells were made. Starter culture 
was grown by inoculating 5.0 mL of LB-broth with a colony of the wild type B.subtilis 
168 cells and incubating aerobically at 37
0 
C/220 rpm. 2.0 mL of this starter culture was 
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used to inoculate the bigger batches (50 mls) of the liquid media and the growth was 
spectrophotometrically monitored at 595 nm. Growth curves were obtained for triplicates 
of the cultures
30, 31
.  
Looking athe growth curves (Figure 56), it seems like, BS 168 cells reach the 
stationary in about 550 minutes. The transistion from exponential to stationary phase 
seems to take place at about 400 minutes from the time the culutures were initiated.  
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Figure 56: Triplicate of the growth curves of BS 168 cells in LB-broth. 
